<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Risk scoring for the primary prevention of cardiovascular disease - Karmali, KN - 2017 | Cochrane Library</title> <meta content="Risk scoring for the primary prevention of cardiovascular disease - Karmali, KN - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006887.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Risk scoring for the primary prevention of cardiovascular disease - Karmali, KN - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006887.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006887.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Risk scoring for the primary prevention of cardiovascular disease" name="citation_title"/> <meta content="Kunal N Karmali" name="citation_author"/> <meta content="Northwestern University Feinberg School of Medicine" name="citation_author_institution"/> <meta content="Kunal.Karmali@nm.org" name="citation_author_email"/> <meta content="Stephen D Persell" name="citation_author"/> <meta content="Northwestern University" name="citation_author_institution"/> <meta content="Pablo Perel" name="citation_author"/> <meta content="London School of Hygiene and Tropical Medicine" name="citation_author_institution"/> <meta content="Donald M Lloyd-Jones" name="citation_author"/> <meta content="Northwestern University Feinberg School of Medicine" name="citation_author_institution"/> <meta content="Mark A Berendsen" name="citation_author"/> <meta content="Northwestern University" name="citation_author_institution"/> <meta content="Mark D Huffman" name="citation_author"/> <meta content="Northwestern University Feinberg School of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD006887.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006887.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006887.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006887.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticholesteremic Agents [therapeutic use]; Antihypertensive Agents [therapeutic use]; Blood Pressure; Cardiovascular Diseases [blood, etiology, *prevention &amp; control]; Cholesterol [blood]; Heart Diseases [prevention &amp; control]; Primary Prevention [*methods]; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006887.pub4&amp;doi=10.1002/14651858.CD006887.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="Oy81c7tH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006887\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006887\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006887.pub4",title:"Risk scoring for the primary prevention of cardiovascular disease",firstPublishedDate:"Mar 14, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006887.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006887.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006887.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006887.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006887.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006887.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006887.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006887.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006887.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006887.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9376 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006887.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/appendices#CD006887-sec-0090"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/supinfo/CD006887StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/supinfo/CD006887StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Risk scoring for the primary prevention of cardiovascular disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Kunal N Karmali</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0005">Stephen D Persell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0006">Pablo Perel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0007">Donald M Lloyd-Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0008">Mark A Berendsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information#CD006887-cr-0009">Mark D Huffman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information/en#CD006887-sec-0101">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006887.pub4">https://doi.org/10.1002/14651858.CD006887.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006887-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006887-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006887-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006887-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006887-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006887-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006887-abs-0001" lang="en"> <section id="CD006887-sec-0001"> <h3 class="title" id="CD006887-sec-0001">Background</h3> <p>The current paradigm for cardiovascular disease (CVD) emphasises absolute risk assessment to guide treatment decisions in primary prevention. Although the derivation and validation of multivariable risk assessment tools, or CVD risk scores, have attracted considerable attention, their effect on clinical outcomes is uncertain. </p> </section> <section id="CD006887-sec-0002"> <h3 class="title" id="CD006887-sec-0002">Objectives</h3> <p>To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes, risk factor levels, preventive medication prescribing, and health behaviours. </p> </section> <section id="CD006887-sec-0003"> <h3 class="title" id="CD006887-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library (2016, Issue 2), MEDLINE Ovid (1946 to March week 1 2016), Embase (embase.com) (1974 to 15 March 2016), and Conference Proceedings Citation Index‐Science (CPCI‐S) (1990 to 15 March 2016). We imposed no language restrictions. We searched clinical trial registers in March 2016 and handsearched reference lists of primary studies to identify additional reports. </p> </section> <section id="CD006887-sec-0004"> <h3 class="title" id="CD006887-sec-0004">Selection criteria</h3> <p>We included randomised and quasi‐randomised trials comparing the systematic provision of CVD risk scores by a clinician, healthcare professional, or healthcare system compared with usual care (i.e. no systematic provision of CVD risk scores) in adults without CVD. </p> </section> <section id="CD006887-sec-0005"> <h3 class="title" id="CD006887-sec-0005">Data collection and analysis</h3> <p>Three review authors independently selected studies, extracted data, and evaluated study quality. We used the Cochrane 'Risk of bias' tool to assess study limitations. The primary outcomes were: CVD events, change in CVD risk factor levels (total cholesterol, systolic blood pressure, and multivariable CVD risk), and adverse events. Secondary outcomes included: lipid‐lowering and antihypertensive medication prescribing in higher‐risk people. We calculated risk ratios (RR) for dichotomous data and mean differences (MD) or standardised mean differences (SMD) for continuous data using 95% confidence intervals. We used a fixed‐effects model when heterogeneity (I²) was at least 50% and a random‐effects model for substantial heterogeneity (I² &gt; 50%). We evaluated the quality of evidence using the GRADE framework. </p> </section> <section id="CD006887-sec-0006"> <h3 class="title" id="CD006887-sec-0006">Main results</h3> <p>We identified 41 randomised controlled trials (RCTs) involving 194,035 participants from 6422 reports. We assessed studies as having high or unclear risk of bias across multiple domains. Low‐quality evidence evidence suggests that providing CVD risk scores may have little or no effect on CVD events compared with usual care (5.4% versus 5.3%; RR 1.01, 95% confidence interval (CI) 0.95 to 1.08; I² = 25%; 3 trials, N = 99,070). Providing CVD risk scores may reduce CVD risk factor levels by a small amount compared with usual care. Providing CVD risk scores reduced total cholesterol (MD −0.10 mmol/L, 95% CI −0.20 to 0.00; I² = 94%; 12 trials, N = 20,437, low‐quality evidence), systolic blood pressure (MD −2.77 mmHg, 95% CI −4.16 to −1.38; I² = 93%; 16 trials, N = 32,954, low‐quality evidence), and multivariable CVD risk (SMD −0.21, 95% CI −0.39 to −0.02; I² = 94%; 9 trials, N = 9549, low‐quality evidence). Providing CVD risk scores may reduce adverse events compared with usual care, but results were imprecise (1.9% versus 2.7%; RR 0.72, 95% CI 0.49 to 1.04; I² = 0%; 4 trials, N = 4630, low‐quality evidence). Compared with usual care, providing CVD risk scores may increase new or intensified lipid‐lowering medications (15.7% versus 10.7%; RR 1.47, 95% CI 1.15 to 1.87; I² = 40%; 11 trials, N = 14,175, low‐quality evidence) and increase new or increased antihypertensive medications (17.2% versus 11.4%; RR 1.51, 95% CI 1.08 to 2.11; I² = 53%; 8 trials, N = 13,255, low‐quality evidence). </p> </section> <section id="CD006887-sec-0007"> <h3 class="title" id="CD006887-sec-0007">Authors' conclusions</h3> <p>There is uncertainty whether current strategies for providing CVD risk scores affect CVD events. Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher‐risk people without evidence of harm. There were multiple study limitations in the identified studies and substantial heterogeneity in the interventions, outcomes, and analyses, so readers should interpret results with caution. New models for implementing and evaluating CVD risk scores in adequately powered studies are needed to define the role of applying CVD risk scores in primary CVD prevention. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006887-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006887-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006887-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006887-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006887-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006887-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006887-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD006887-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006887-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD006887-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006887-abs-0002" lang="en"> <h3>Clinical effects of cardiovascular risk scores in people without cardiovascular disease</h3> <p><i><b>Review question</b> </i> </p> <p>What is the evidence about the potential clinical benefits and harms of providing cardiovascular disease (CVD) risk scores in people without a history of heart disease or stroke? </p> <p><i><b>Background</b> </i> </p> <p>Cardiovascular disease (CVD) is a group of conditions that includes heart disease and stroke. CVD prevention guidelines emphasise the use of risk scores, equations that use clinical variables to estimate the chance of a first heart attack or stroke, to guide treatment decisions in the general population. While there has been much attention to developing different types of CVD risk scores, there is uncertainty about the effects of providing a CVD risk score in clinical practice. </p> <p>The aim of this systematic review was to assess the effects of evaluating CVD risk scores in adults without a history of heart disease or stroke on cardiovascular outcomes, risk factor levels, preventive medication prescribing, and health behaviours. </p> <p><i><b>Study characteristics</b> </i> </p> <p>We searched scientific databases for randomised trials (clinical studies that randomly put people into different treatment groups) that systematically provided CVD risk scores or usual care to adults without a history of heart disease or stroke. The evidence is current to March 2016. Funding for the majority of trials came from government sources or pharmaceutical companies. </p> <p><i><b>Key results</b> </i> </p> <p>We identified 41 trials that included 194,035 participants. Many of the studies had limitations. Low‐quality evidence suggests that providing CVD risk scores had little or no effect on the number of people who develop heart disease or stroke. Providing CVD risk scores may reduce CVD risk factor levels (like cholesterol, blood pressure, and multivariable CVD risk) by a small amount and may increase cholesterol‐lowering and blood pressure‐lowering medication prescribing in higher risk people. Providing CVD risk scores may reduce harms, but the results were imprecise. </p> <p><i><b>Quality of the evidence</b> </i> </p> <p>There is low‐quality evidence to guide the use of CVD risk scores in clinical practice. Studies had multiple limitations and used different methods to provide CVD risk scores. It is likely that further research will influence these results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006887-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006887-sec-0085"></div> <h3 class="title" id="CD006887-sec-0086">Implications for practice</h3> <section id="CD006887-sec-0086"> <p>Due to the low‐quality evidence available, we are unable to draw firm conclusions about the clinical effectiveness of providing CVD risk scores in primary CVD prevention. Providing CVD risk scores may increase lipid‐lowering and blood pressure‐lowering medication prescribing in higher risk people and may have a small effect on reducing cardiovascular risk factor levels; however, there is insufficient high‐quality evidence to determine whether this translates into improved CVD outcomes. For clinical outcomes, not only was there low‐quality evidence, but only three studies reported this endpoint. Much uncertainty remains about the optimal implementation of CVD risk scores in clinical practice to improve cardiovascular health outcomes. </p> </section> <h3 class="title" id="CD006887-sec-0087">Implications for research</h3> <section id="CD006887-sec-0087"> <p>In spite of the widespread promulgation of CVD risk scores in prevention guidelines, there is low‐quality evidence and several gaps in evidence for guiding implementation in practice. Given the low event rates in primary prevention, it may not be feasible or practical to conduct a study with a large enough size and duration to determine the effects of providing CVD risk scores on CVD outcomes. Future studies should clearly identify how well the intended CVD risk score application was implemented in practice and evaluate its effectiveness in studies powered to identify reductions in causal risk factor levels. Moreover, studies should identify the optimal content and format of CVD risk messages that motivate behaviour change in physicians and patients, assess the impact of providing CVD risk information longitudinally over time, and look beyond initiation of evidence‐based risk‐reducing therapies to address uptake and long‐term adherence to these therapies to achieve risk factor changes and eventual improvements in health outcomes. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006887-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006887-sec-0008"></div> <div class="table" id="CD006887-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">CVD risk scoring for the primary prevention of cardiovascular disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CVD risk scoring for the primary prevention of cardiovascular disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population</b> : adults without prevalent cardiovascular disease (primary cardiovascular disease prevention)<br/><b>Setting</b> : outpatient<br/><b>Intervention</b> : providing CVD risk scores<br/><b>Comparison</b>: not providing CVD risk scores/usual care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>N of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with not providing CVD risk scores/usual care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with providing CVD risk scores</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>CVD events<br/>follow‐up: range 1‐10 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.01<br/>(0.95 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99,070<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>53 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/>(51 to 58) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total cholesterol (mmol/L)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean total cholesterol level was 5.1 to 6.6 mmol/L and the range of mean change from baseline in total cholesterol level was 0.09 lower to 0.14 mmol/L higher </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in total cholesterol in the intervention group was 0.10 mmol/L lower<br/>(0.20 lower to 0.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,437<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure (mmHg)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean systolic blood pressure level was 124.1 to 159.0 mmHg and the range of mean change from baseline in systolic blood pressure level was 5.3 lower to 1.0 higher mmHg </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in systolic blood pressure in the intervention group was 2.77 mmHg lower<br/>(4.16 lower to 1.38 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32,954<br/>(16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in multivariable CVD risk (SD)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean change from baseline in multivariable CVD risk was 5.3 lower to 0.77 higher SDs </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in multivariable CVD risk in the intervention group was 0.21 SDs lower<br/>(0.39 lower to 0.02 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9549<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised mean differences were calculated for this outcome due to the use of different multivariable CVD risk scales. An effect size of ~0.20 SD units reflects a small effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Investigator‐defined adverse events<br/>follow‐up: range 1 month to 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.72<br/>(0.49 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4630<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events were defined heterogeneously by investigators and included some events that may have been due to newly prescribed medications rather than the provision of a CVD risk score itself. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000<br/>(13 to 28) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>New/intensified lipid‐lowering medication<br/>follow‐up: median 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.47<br/>(1.15 to 1.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,175<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prescribing rates in the comparison group varied among the included trials (range 4% to 22%). Median prescribing rate presented </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/>(123 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>New/intensified antihypertensive medication<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.51<br/>(1.08 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,255<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prescribing rates in the comparison group varied among the included trials (range 0% to 27%). Median prescribing rate presented </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>172 per 1000<br/>(123 to 240) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI</b> : confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR</b> : risk ratio; <b>SD</b>: standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low quality</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded due to study limitations, primarily driven by high risk of selection bias in <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a> and high risk of reporting bias in <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a> and <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>.<br/><sup>b</sup>Downgraded due to imprecision; trials reported being underpowered for CVD events.<br/><sup>c</sup>Downgraded due to study limitations, primarily in the domains of attrition bias (missing data for follow‐up risk factor levels) and other sources of bias (poor intervention fidelity, potential conflicts of interest).<br/><sup>d</sup>Downgraded due to heterogeneity in pooled estimates.<br/><sup>e</sup>Downgraded due to study limitations, primarily in the domains of attrition bias (missing data for medication prescribing in follow‐up) and other sources of bias (poor intervention fidelity, potential conflicts of interest).<br/><sup>f</sup>Downgraded due to imprecision, because confidence interval includes 1 and sample size does not meet threshold for optimal information size. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006887-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006887-sec-0009"></div> <section id="CD006887-sec-0010"> <h3 class="title" id="CD006887-sec-0010">Description of the condition</h3> <p>Cardiovascular disease (CVD), which includes ischaemic heart disease and stroke, is the leading cause of mortality and disability worldwide (<a href="./references#CD006887-bbs2-0155" title="MurrayCJ , VosT , LozanoR , NaghaviM , FlaxmanAD , MichaudC , et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380(9859):2197-223. [PMID: 23245608]">Murray 2012</a>; <a href="./references#CD006887-bbs2-0156" title="NaghaviM , WangH , LozanoR , DavisA , LiangX , ZhouM , et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet2015;385(9963):117-71.">Naghavi 2015</a>). According to the Global Burden of Disease study, ischaemic heart disease and stroke accounted for 12.9 million deaths worldwide in 2013, or one in every four of the total (<a href="./references#CD006887-bbs2-0156" title="NaghaviM , WangH , LozanoR , DavisA , LiangX , ZhouM , et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet2015;385(9963):117-71.">Naghavi 2015</a>). CVD is also costly, and the World Economic Forum estimates that the direct cost attributable to CVD is USD 863 billion worldwide, with a projected rise of 22% by 2030 (<a href="./references#CD006887-bbs2-0139" title="BloomDE , CafieroET , Jané-LlopisE , Abrahams-GesselS , BloomLR , FathimaS , et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum, 2011.">Bloom 2011</a>). </p> <p>The incidence of CVD is largely explained by several modifiable risk factors, which include abnormal cholesterol, elevated blood pressure, diabetes mellitus, smoking, unhealthy diet, excessive alcohol intake, abdominal obesity, psychosocial stress, and lack of physical activity. These nine modifiable risk factors increase the risk of future CVD events and contribute to an estimated 90% of the population attributable risk fraction of ischaemic heart disease and stroke worldwide (<a href="./references#CD006887-bbs2-0159" title="O'DonnellMJ , XavierD , LiuL , ZhangH , ChinSL , Rao-MelaciniP , et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet2010;376(9735):112-23. [PMID: 20561675]">O'Donnell 2010</a>; <a href="./references#CD006887-bbs2-0173" title="YusufS , HawkenS , OunpuuS , DansT , AvezumA , LanasF , et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet2004;364(9438):937-52. [PMID: 15364185]">Yusuf 2004</a>). Prevention, treatment, and control of these risk factors before clinical manifestation are therefore primary targets of interventions to reduce the burden of CVD. </p> </section> <section id="CD006887-sec-0011"> <h3 class="title" id="CD006887-sec-0011">Description of the intervention</h3> <p>CVD events are often determined by the confluence of multiple, co‐existing risk factors (<a href="./references#CD006887-bbs2-0165" title="Smith SC Jr, JacksonR , PearsonTA , FusterV , YusufS , FaergemanO , et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation2004;109(25):3112-21. [PMID: 15226228]">Smith 2004</a>). The multifactorial nature of CVD has led to the development and application of multivariable risk assessment tools, or CVD risk scores, to calculate CVD risk. CVD risk scores allow clinicians to integrate information from multiple CVD risk factors and quantitatively estimate a person's absolute risk for, or likelihood of experiencing, a CVD event during a defined period of time. </p> <p>The first widely used multivariable CVD risk score was derived from the Framingham Heart Study in the USA (<a href="./references#CD006887-bbs2-0134" title="AndersonKM , OdellPM , WilsonPW , KannelWB . Cardiovascular disease risk profiles. American Heart Journal1991;121(1 Pt 2):293-8. [PMID: 1985385]">Anderson 1991</a>; <a href="./references#CD006887-bbs2-0171" title="WilsonPW , D'AgostinoRB , LevyD , BelangerAM , SilbershatzH , KannelWB . Prediction of coronary heart disease using risk factor categories. Circulation1998;97(18):1837-47. [PMID: 9603539]">Wilson 1998</a>). The Framingham risk score incorporated the effects of age, sex, systolic blood pressure, total cholesterol, high‐density lipoprotein (HDL) cholesterol, smoking status, antihypertensive treatment status, and diabetes mellitus to estimate 10‐year risk of coronary heart disease. During the past two decades, there has been widespread development of additional CVD risk scores such as the European Systematic COronary Risk Evaluation (SCORE) algorithm (<a href="./references#CD006887-bbs2-0142" title="ConroyRM , PyöräläK , FitzgeraldAP , SansS , MenottiA , De BackerG , et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal2003;24(11):987-1003. [PMID: 12788299]">Conroy 2003</a>); the German Prospective Cardiovascular Munster (PROCAM) model (<a href="./references#CD006887-bbs2-0136" title="AssmannG , CullenP , SchulteH . Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation2002;105(3):310-5. [PMID: 11804985]">Assmann 2002</a>); the UK QRISK and QRISK2 equations (<a href="./references#CD006887-bbs2-0150" title="Hippisley-CoxJ , CouplandC , VinogradovaY , RobsonJ , MayM , BrindleP . Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ2007;335(7611):136. [PMID: 17615182]">Hippisley‐Cox 2007</a>; <a href="./references#CD006887-bbs2-0151" title="Hippisley-CoxJ , CouplandC , VinogradovaY , RobsonJ , MinhasR , SheikhA , et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ2008;336(7659):1475-82. [PMID: 18573856]">Hippisley‐Cox 2008</a>); the World Health Organization (WHO) risk chart (<a href="./references#CD006887-bbs2-0169" title="World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.">WHO 2007</a>); the American College of Cardiology (ACC)/American Heart Association (AHA) 2013 Pooled Cohort risk equations (<a href="./references#CD006887-bbs2-0145" title="Goff DC Jr, Lloyd-JonesDM , BennettG , CoadyS , D'Agostino RB Sr, GibbonsR , et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2014;129(25 Suppl 2):S49-73. [PMID: 24222018]">Goff 2014</a>); and the Globorisk cardiovascular risk equation for use globally, including in low‐ and middle‐income countries (<a href="./references#CD006887-bbs2-0148" title="HajifathalianK , UedaP , LuY , WoodwardM , AhmadvandA , Aguilar-SalinasCA , et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes &amp; Endocrinology2015;3(5):339-55.">Hajifathalian 2015</a>). CVD prevention guidelines recommend use of these risk scores to guide treatment decisions for primary prevention in people who do not yet have clinical manifestations of CVD (<a href="./references#CD006887-bbs2-0135" title="AndersonTJ , GrégoireJ , HegeleRA , CoutureP , ManciniGB , McPhersonR , et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology2013;29(2):151-67. [PMID: 23351925]">Anderson 2013</a>; <a href="./references#CD006887-bbs2-0157" title="National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation2002;106(25):3143-421. [PMID: 12485966]">NCEP 2002</a>; <a href="./references#CD006887-bbs2-0158" title="National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).">NICE 2014</a>; <a href="./references#CD006887-bbs2-0160" title="PiepoliMF , HoesAW , AgewallS , AlbusC , BrotonsC , CatapanoAL , et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal2016;37(29):2315-81. [PMID: 27222591]">Piepoli 2016</a>; <a href="./references#CD006887-bbs2-0166" title="StoneNJ , RobinsonJ , LichtensteinAH , Bairey MerzCN , BlumCB , EckelRH , et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;129(25 Suppl 2):S1-45. [PMID: 24222016]">Stone 2014</a>; <a href="./references#CD006887-bbs2-0169" title="World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.">WHO 2007</a>). </p> </section> <section id="CD006887-sec-0012"> <h3 class="title" id="CD006887-sec-0012">How the intervention might work</h3> <p>The current paradigm for CVD risk reduction in primary prevention matches the intensity of prevention efforts to a person's absolute risk for developing CVD (<a href="./references#CD006887-bbs2-0138" title="No authors listed. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995. Journal of the American College of Cardiology1996;27(5):957-1047. [PMID: 8609361]">Bethesda 1996</a>; <a href="./references#CD006887-bbs2-0165" title="Smith SC Jr, JacksonR , PearsonTA , FusterV , YusufS , FaergemanO , et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation2004;109(25):3112-21. [PMID: 15226228]">Smith 2004</a>). Risk‐based prevention, therefore, directs treatments toward people at increased risk who derive greater benefit from treatment, while sparing people at lower risk for whom benefits may not outweigh the costs and harms of treatment. Qualitative assessment of CVD risk, however, is fraught with error, thereby providing a rationale for quantitative risk assessment tools (<a href="./references#CD006887-bbs2-0146" title="GroverSA , LowensteynI , EsreyKL , SteinertY , JosephL , AbrahamowiczM . Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ1995;310(6985):975-8. [PMID: 7728035]">Grover 1995</a>; <a href="./references#CD006887-bbs2-0154" title="MelandE , LaerumE , StensvoldI . Assessment of coronary heart disease risk, I. A postal inquiry among primary care physicians. Family Practice1994;11(2):117-21. [PMID: 7958572]">Meland 1994</a>; <a href="./references#CD006887-bbs2-0161" title="PignoneM , PhillipsCJ , ElasyTA , FernandezA . Physicians' ability to predict the risk of coronary heart disease. BMC Health Services Research2003;3(1):13. [PMID: 12857356]">Pignone 2003</a>; <a href="./references#CD006887-bbs2-0168" title="Van der WeijdenT , BosLB , Koelewijn-van LoonMS . Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice. Current Opinion in Cardiology2008;23(5):471-6. [PMID: 18670259]">Van der Weijden 2008</a>). Prevention guidelines in the USA, the UK, Europe, Canada, and the developing world promote the use of multivariable CVD risk scores to guide treatment decisions in primary prevention (<a href="./references#CD006887-bbs2-0135" title="AndersonTJ , GrégoireJ , HegeleRA , CoutureP , ManciniGB , McPhersonR , et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology2013;29(2):151-67. [PMID: 23351925]">Anderson 2013</a>; <a href="./references#CD006887-bbs2-0157" title="National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation2002;106(25):3143-421. [PMID: 12485966]">NCEP 2002</a>; <a href="./references#CD006887-bbs2-0158" title="National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).">NICE 2014</a>; <a href="./references#CD006887-bbs2-0160" title="PiepoliMF , HoesAW , AgewallS , AlbusC , BrotonsC , CatapanoAL , et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal2016;37(29):2315-81. [PMID: 27222591]">Piepoli 2016</a>; <a href="./references#CD006887-bbs2-0166" title="StoneNJ , RobinsonJ , LichtensteinAH , Bairey MerzCN , BlumCB , EckelRH , et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;129(25 Suppl 2):S1-45. [PMID: 24222016]">Stone 2014</a>; <a href="./references#CD006887-bbs2-0169" title="World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.">WHO 2007</a>). The 2013 ACC/AHA Cholesterol Guidelines in the USA, described in <a href="./references#CD006887-bbs2-0166" title="StoneNJ , RobinsonJ , LichtensteinAH , Bairey MerzCN , BlumCB , EckelRH , et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;129(25 Suppl 2):S1-45. [PMID: 24222016]">Stone 2014</a>, and the National Institute for Health and Care Excellence (NICE) recommendations for the prevention of CVD in the UK, laid out in <a href="./references#CD006887-bbs2-0158" title="National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).">NICE 2014</a>, both advocate risk‐based prevention strategies that incorporate multivariable CVD risk scores to estimate short‐ and long‐term CVD risk, providing a quantitative framework to guide clinician‐patient discussions regarding statins in primary prevention. </p> <p>Analyses of randomised clinical trials (RCTs) provide empiric support for risk stratification by demonstrating that the absolute risk reduction from preventive medications is related more to the magnitude of pretreatment risk than the relative risk reduction associated with treating a single risk factor (<a href="./references#CD006887-bbs2-0140" title="Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC), SundströmJ , ArimaH , WoodwardM , JacksonR , KarmaliK , et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet2014;384(9943):591-8. [PMID: 25131978]">BPLTTC 2014</a>; <a href="./references#CD006887-bbs2-0143" title="Cholesterol Treatment Trialists' (CTT) Collaborators, MihaylovaB , EmbersonJ , BlackwellL , KeechA , SimesJ , et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet2012;380(9841):581-90. [PMID: 22607822]">CTT 2012</a>; <a href="./references#CD006887-bbs2-0152" title="JacksonR , LawesCM , BennettDA , MilneRJ , RodgersA . Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet2005;365(9457):434-41. [PMID: 15680460]">Jackson 2005</a>). Therefore, use of CVD risk scores not only has the potential to effectively and efficiently direct preventive care to those in greatest need but may help maximise benefit of treatment in high‐risk people and minimise harms of over‐treatment in people at low risk. Additional purported benefits of CVD risk scores also include raising awareness of disease, improving communication between clinician and patient, and motivating adherence to recommended lifestyle changes or preventive therapies (<a href="./references#CD006887-bbs2-0145" title="Goff DC Jr, Lloyd-JonesDM , BennettG , CoadyS , D'Agostino RB Sr, GibbonsR , et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation2014;129(25 Suppl 2):S49-73. [PMID: 24222018]">Goff 2014</a>). </p> </section> <section id="CD006887-sec-0013"> <h3 class="title" id="CD006887-sec-0013">Why it is important to do this review</h3> <p>Although considerable research has focused on the derivation and validation of multivariable CVD risk prediction tools in different populations, the effects of CVD risk scores to direct clinical practice is poorly understood, and few studies have examined their utility in clinical practice (<a href="./references#CD006887-bbs2-0144" title="DamenJA , HooftL , SchuitE , DebrayTP , CollinsGS , TzoulakiI , et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ2016;353:i2416. [PMID: 27184143]">Damen 2016</a>). In 2006 and 2008, two related systematic reviews performed with Cochrane methodology identified only four RCTs testing the clinical effects of CVD risk scores and found no clear evidence that CVD risk assessment improved health outcomes (<a href="./references#CD006887-bbs2-0137" title="BeswickAD , BrindleP , FaheyT , EbrahimS . A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PMID: 21834196]">Beswick 2008</a>; <a href="./references#CD006887-bbs2-0141" title="BrindleP , BeswickA , FaheyT , EbrahimS . Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart2006;92(12):1752-9. [PMID: 16621883]">Brindle 2006</a>). In 2008, a systematic review examining the clinical benefits or harms of providing CVD risk scores identified six trials showing that physicians presented with risk information tended to appropriately prescribe preventive therapies (<a href="./references#CD006887-bbs2-0163" title="SheridanSL , CrespoE . Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research2008;8:60. [PMID: 18366711]">Sheridan 2008</a>). Another systematic review examining the effect of giving CVD risk information to adults in clinical practice identified 18 studies (14 RCTs) demonstrating that global CVD risk information improved accuracy of risk perception and increased patients' intent to start pharmacotherapy (<a href="./references#CD006887-bbs2-0164" title="SheridanSL , VieraAJ , KrantzMJ , IceCL , SteinmanLE , PetersKE , et al. The effect of giving global coronary risk information to adults: a systematic review. Archives of Internal Medicine2010;170(3):230-9. [PMID: 20142567]">Sheridan 2010</a>). However, in both reviews the effect of CVD risk scores on health outcomes, risk factors, and health behaviours was unclear. </p> <p>In spite of widespread recommendations for the use of multivariable CVD risk scores in clinical practice guidelines (<a href="./references#CD006887-bbs2-0135" title="AndersonTJ , GrégoireJ , HegeleRA , CoutureP , ManciniGB , McPhersonR , et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology2013;29(2):151-67. [PMID: 23351925]">Anderson 2013</a>; <a href="./references#CD006887-bbs2-0157" title="National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation2002;106(25):3143-421. [PMID: 12485966]">NCEP 2002</a>; <a href="./references#CD006887-bbs2-0158" title="National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).">NICE 2014</a>; <a href="./references#CD006887-bbs2-0160" title="PiepoliMF , HoesAW , AgewallS , AlbusC , BrotonsC , CatapanoAL , et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal2016;37(29):2315-81. [PMID: 27222591]">Piepoli 2016</a>; <a href="./references#CD006887-bbs2-0166" title="StoneNJ , RobinsonJ , LichtensteinAH , Bairey MerzCN , BlumCB , EckelRH , et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;129(25 Suppl 2):S1-45. [PMID: 24222016]">Stone 2014</a>; <a href="./references#CD006887-bbs2-0169" title="World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.">WHO 2007</a>), uncertainty remains about their effects on health‐related outcomes. Given the publication of new trials and the continued prominence of multivariable CVD risk scores in primary CVD prevention guidelines, a systematic review of the literature is warranted. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006887-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006887-sec-0014"></div> <p>To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes, risk factor levels, preventive medication prescribing, and health behaviours. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006887-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006887-sec-0015"></div> <section id="CD006887-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006887-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included RCTs and quasi‐RCTs (systematic allocation) with individual or cluster allocation. We included studies reported as full text and abstracts as well as unpublished data. </p> </section> <section id="CD006887-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies that reported results for adults (18 years of age and older) in outpatient settings free of clinical CVD (defined as prior heart attack, stroke, heart failure, symptomatic peripheral vascular disease, or atrial fibrillation). Participants with diabetes mellitus or elevated risk factors as well as those already on background preventive medications were eligible for inclusion. For studies that included a combination of participants with and without prevalent CVD, we included studies that reported results for primary prevention participants. When studies included both primary and secondary prevention populations, we included only those studies with &lt; 30% of the study population having prevalent CVD. </p> </section> <section id="CD006887-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included trials that compared the systematic provision of a multivariable CVD risk score by a clinician, healthcare professional, or healthcare system versus usual care (i.e. no systematic provision of a CVD risk score) in primary CVD prevention. We excluded health risk appraisals not based on a risk score and studies testing risk of hypothetical patients. </p> </section> <section id="CD006887-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD006887-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006887-list-0001"> <li> <p>CVD events (a composite of fatal and non‐fatal myocardial infarction and stroke)</p> </li> <li> <p>Change in risk factor levels</p> <ol id="CD006887-list-0002"> <li> <p>Cholesterol: total cholesterol, low‐density lipoprotein (LDL) cholesterol</p> </li> <li> <p>Blood pressure: systolic blood pressure, diastolic blood pressure</p> </li> <li> <p>Change in multivariable CVD risk: a summary score or risk estimate that incorporates multiple and simultaneous changes in different CVD risk factor levels </p> </li> </ol> </li> <li> <p>Investigator‐defined adverse events, including but not limited to physical or psychosocial events, including anxiety or depression </p> </li> </ol> </p> </section> <section id="CD006887-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006887-list-0003"> <li> <p>Preventive medication prescribing in higher risk people</p> <ol id="CD006887-list-0004"> <li> <p>Lipid‐lowering medications</p> </li> <li> <p>Antihypertensive medications</p> </li> <li> <p>Aspirin</p> </li> </ol> </li> <li> <p>Medication adherence</p> </li> <li> <p>Health‐related behaviours</p> <ol id="CD006887-list-0005"> <li> <p>Smoking cessation</p> </li> <li> <p>Exercise</p> </li> <li> <p>Diet</p> </li> </ol> </li> <li> <p>Decisional conflict, measured according to the decisional conflict scale</p> </li> <li> <p>Health‐related quality of life, measured according to any validated scale concerning quality of life </p> </li> <li> <p>Costs</p> </li> </ol> </p> </section> </section> </section> <section id="CD006887-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>Key inclusion criteria were studies that were relevant to CVD primary prevention, employed a prospective design, and provided or incorporated a CVD risk score to guide treatment decisions in CVD prevention. </p> <p>Exclusion criteria were studies that were unrelated to CVD risk scores; those addressing health risk appraisals not based on a quantitative risk score; those relying only on self‐reported risk factors and lifestyle; and those involving clinical vignettes or hypothetical patients rather than real patients. </p> <section id="CD006887-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified trials through systematic searches of the following bibliographic databases on 15 March 2016. </p> <p> <ul id="CD006887-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016 Issue 2) in the Cochrane Library (Wiley). </p> </li> <li> <p>Ovid MEDLINE(R) (1946 to March Week 1 2016).</p> </li> <li> <p>Ovid MEDLINE(R) In‐Process &amp; Other Non‐Indexed Citations (14 March 2016).</p> </li> <li> <p>Embase, including Embase Classic, via embase.com (1947 to 15 March 2016).</p> </li> <li> <p>Conference Proceedings Citation Index‐Science (CPCI‐S) via Web of Science (1990 to 15 March 2016). </p> </li> </ul> </p> <p>Two authors (KNK, MAB) designed the database searches based on the MEDLINE search strategy used in a previous systematic review published with Cochrane methodology (<a href="./references#CD006887-bbs2-0137" title="BeswickAD , BrindleP , FaheyT , EbrahimS . A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PMID: 21834196]">Beswick 2008</a>). The search strategies for each database are available in <a href="./appendices#CD006887-sec-0091">Appendix 1</a>. For the MEDLINE search, we applied the Cochrane sensitivity and precision maximizing RCT filter (<a href="./references#CD006887-bbs2-0153" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Lefebvre 2011</a>). For Embase, we translated from Ovid to embase.com syntax, the multiterm Embase filter with the best balance of sensitivity and specificity (<a href="./references#CD006887-bbs2-0172" title="WongSS , WilczynskiNL , HaynesRB . Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. Journal of the Medical Library Association2006;94(1):41-7.">Wong 2006</a>), and we limited the search to records indexed in Embase. For Conference Proceedings Citation Index‐Science we used a combination of terms for identifying trials described in section 6.3.2.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006887-bbs2-0153" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Lefebvre 2011</a>). We applied no filters to the CENTRAL search. </p> <p>We searched all databases from their inception to March 2016, and we imposed no restriction on language of publication. </p> </section> <section id="CD006887-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We tried to identify other potentially eligible trials or ancillary publications by searching the reference lists of retrieved included studies and relevant review articles for additional references. We also searched ClinicalTrials.gov (<a href="http://www.ClinicalTrials.gov" target="_blank">www.ClinicalTrials.gov</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) on 16 March 2016. Lastly, we contacted study authors of included or registered trials to identify further studies or unpublished data that could contribute to our review. </p> </section> </section> <section id="CD006887-sec-0026"> <h3 class="title" id="CD006887-sec-0026">Data collection and analysis</h3> <section id="CD006887-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Three authors (KNK and SDP or MDH) independently screened titles and abstracts of every record retrieved to determine which studies to assess further, resolving disagreements by consensus. We then retrieved full‐text study reports/publications of all eligible or potentially eligible reports. Three authors (KNK and SDP or MDH) independently screened full‐text articles, identified studies for inclusion, and recorded reasons for exclusion of the ineligible studies. We resolved any disagreements through discussion or, if required, recourse to the third author (SDP or MDH). We identified and excluded duplicate reports and collated multiple reports of the same study so that each study, rather than each report, was the unit of analysis. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and <a href="./references#CD006887-sec-0108" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD006887-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>For studies that fulfilled the inclusion criteria, we used standardised data extraction forms to record study characteristics and outcome data. We extracted the following study characteristics. </p> <p> <ol id="CD006887-list-0007"> <li> <p>Methods: study design, total duration of study, details of any run‐in period, number of study centres and location, study country and setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: N, mean age, age range, sex, severity of condition, diagnostic criteria, baseline CVD risk, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: CVD risk score used, comparator group.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Three authors (KNK and SDP or MDH) independently extracted outcome data from included studies in duplicate. We resolved disagreements by consensus or by involving the third author. One author (KNK) transferred data into Review Manager 5 (<a href="./references#CD006887-bbs2-0162" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>), and another author (SDP) spot‐checked to ensure that study characteristics and study data were entered correctly. </p> </section> <section id="CD006887-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three authors (KNK and SDP or MDH) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We resolved disagreements by consensus or by involving the third author. We assessed risk of bias according to the following domains. </p> <p> <ol id="CD006887-list-0008"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias (e.g. industry funding).</p> </li> </ol> </p> <p>We judged risk of bias criteria as low risk, unclear risk, or high risk and evaluated individual bias items as described in <a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>. When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. For cluster‐RCTs, we followed Cochrane recommendations for assessing risk of bias, with particular attention across the domains of recruitment, baseline imbalances, loss of cluster, incorrect analyses, and comparability with individually RCTs (<a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Two of the review authors (SDP and DLJ) performed two studies included in this review (<a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>). For these two studies, data extraction and risk of bias assessment were performed by review authors who were not involved with the conduct of either study (KNK and MDH). </p> <section id="CD006887-sec-0030"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to a published protocol and reported any deviations from it in the <a href="#CD006887-sec-0105">Differences between protocol and review</a> section. </p> </section> </section> <section id="CD006887-sec-0031"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risk ratios (RRs) with 95% confidence intervals (CIs). We used inverse variance methods to facilitate meta‐analysis of outcomes from individual RCTs and appropriately analysed cluster‐RCTs (Chapter 16.3.3 of <a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We used <a href="./references#CD006887-bbs2-0162" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a> to convert the reported effect estimates to a common risk ratio format. We analysed continuous data as mean difference (MD) or standardised mean difference (SMD) with 95% CIs. We entered data presented as a scale with a consistent direction of effect. For meta‐analyses of mean differences, we pooled results of studies that reported final values with those reporting changes from baseline (Chapter 9.4.5.2 of <a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). For meta‐analyses of SMDs, we pooled results of studies that reported change from baseline (change scores). </p> </section> <section id="CD006887-sec-0032"> <h4 class="title">Unit of analysis issues</h4> <p>We included RCTs with parallel design and cluster‐RCTs. For cluster‐RCTs, we recorded whether investigators accounted for clustering in their analyses (e.g. multilevel model, generalised estimating equations). If analyses adjusted for clustering, then we meta‐analysed individual RCTs with cluster‐RCTs. For continuous outcomes, we used the inverse‐variance method to calculate MDs and SMDs. For dichotomous outcomes, we used the generic inverse‐variance method to meta‐analyse the reported effect estimate (and corresponding standard error or confidence interval) from the appropriately‐analysed cluster‐RCT and the reported or calculated effect estimate from the individual RCT (Chapter 16.3.3 of <a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </section> <section id="CD006887-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. when a study is identified as abstract only). We investigated attrition rates, losses to follow‐up, withdrawals, and critically appraised methods for handling missing data and imputation methods. If standard deviations for outcomes were not available, we imputed these values from data within the trial using methods outlined in Chapter 16.1.3 of <a href="./references#CD006887-bbs2-0149" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a> and through <a href="./references#CD006887-bbs2-0162" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a> </p> </section> <section id="CD006887-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity among the trials in each analysis. If we identified substantial (I² &gt; 50%) heterogeneity, we reported it and explored possible causes by subgroup analyses.  </p> </section> <section id="CD006887-sec-0035"> <h4 class="title">Assessment of reporting biases</h4> <p>We created and examined a funnel plot to explore possible publication and small study bias for the primary outcomes. </p> </section> <section id="CD006887-sec-0036"> <h4 class="title">Data synthesis</h4> <p>We undertook meta‐analyses only if the treatments, participants, and the underlying clinical questions in the studies were similar enough for pooling to be appropriate. If there was no or moderate heterogeneity (I² &lt; 50%), we performed fixed‐effect model meta‐analyses. If there was substantial heterogeneity (I² &gt; 50%), we performed a random‐effects model meta‐analyses with cautious interpretation. </p> </section> <section id="CD006887-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned on performing the following pre‐specified subgroup analyses on our primary outcomes. </p> <p> <ol id="CD006887-list-0009"> <li> <p>Sex (patient).</p> </li> <li> <p>RCTs versus quasi‐RCTs.</p> </li> <li> <p>Trials providing CVD risk scores to clinicians versus trials providing CVD risk scores to patients. </p> </li> <li> <p>Trials that incorporated a multivariable CVD risk score within a clinical decision support tool (either clinician‐facing or patient‐facing). </p> </li> </ol> </p> <p>Among these prespecified subgroups, we were only able to perform a subgroup analysis among trials that used or did not use a clinical decision support tool. We did not have sufficient data from each trial to perform subgroup analysis by sex. We identified only one quasi‐RCT. Lastly, many studies and protocols were unclear as to whether CVD risk scores were exclusively directed to a clinician or patient. Frequently, such risk scores were provided to both clinicians and patients during a clinical encounter. </p> <p>Based on the substantial heterogeneity identified in our meta‐analysis, we also performed two post hoc subgroup analyses on: </p> <p> <ol id="CD006887-list-0010"> <li> <p>Trials that utilised health information technology (IT) for risk assessment or risk communication. </p> </li> <li> <p>Trials that exclusively enrolled participants with higher risk (defined as 10‐year CVD risk ≥ 10% or a high‐risk condition such as diabetes mellitus). </p> </li> </ol> </p> <p>We used the formal test for subgroup interactions in <a href="./references#CD006887-bbs2-0162" title="Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>. </p> </section> <section id="CD006887-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to carry out sensitivity analyses excluding studies assessed as being at unclear or high risk of bias in any domain. However, we assessed nearly all studies as being at unclear or high risk of bias, so this sensitivity analysis was not performed. </p> </section> <section id="CD006887-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We assessed the quality of the evidence for each outcome according to the GRADE approach and presented results in a 'Summary of findings' table (<a href="./references#CD006887-bbs2-0147" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [PMID: 18436948]">Guyatt 2008</a>). We rated the quality of evidence as: high, moderate, low, or very low after consideration of within‐study risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates, and risk of publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006887-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006887-sec-0040"></div> <section id="CD006887-sec-0041"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD006887-sec-0107" title="">Characteristics of included studies</a>; <a href="./references#CD006887-sec-0108" title="">Characteristics of excluded studies</a>; <a href="./references#CD006887-sec-0109" title="">Characteristics of studies awaiting classification</a>; <a href="./references#CD006887-sec-0110" title="">Characteristics of ongoing studies</a>. </p> <section id="CD006887-sec-0042"> <h4 class="title">Results of the search</h4> <p>We identified 8723 records through database searching and an additional 13 records from prior systematic reviews of this topic (<a href="./references#CD006887-bbs2-0141" title="BrindleP , BeswickA , FaheyT , EbrahimS . Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart2006;92(12):1752-9. [PMID: 16621883]">Brindle 2006</a>; <a href="./references#CD006887-bbs2-0137" title="BeswickAD , BrindleP , FaheyT , EbrahimS . A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PMID: 21834196]">Beswick 2008</a>; <a href="./references#CD006887-bbs2-0163" title="SheridanSL , CrespoE . Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research2008;8:60. [PMID: 18366711]">Sheridan 2008</a>; <a href="./references#CD006887-bbs2-0164" title="SheridanSL , VieraAJ , KrantzMJ , IceCL , SteinmanLE , PetersKE , et al. The effect of giving global coronary risk information to adults: a systematic review. Archives of Internal Medicine2010;170(3):230-9. [PMID: 20142567]">Sheridan 2010</a>; <a href="./references#CD006887-bbs2-0170" title="WillisA , DaviesM , YatesT , KhuntiK . Primary prevention of cardiovascular disease using validated risk scores: a systematic review. Journal of Royal Society of Medicine2012;105(8):348-56.">Willis 2012</a>; <a href="./references#CD006887-bbs2-0167" title="Usher-SmithJA , SilarovaB , SchuitE , MoonsKG , GriffinSJ . Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review. BMJ Open2015;5(10):e008717.">Usher‐Smith 2015</a>). The article selection process is depicted in the PRISMA flowchart in <a href="#CD006887-fig-0001">Figure 1</a>. After removing duplicates, we screened 6422 records and excluded 6238 based on title and abstract. We removed an additional 5 duplicate records and assessed 179 full‐text records and 4 trial registry records for eligibility. We excluded 94 records of 77 studies and 2 trial registry records with reasons, identified 11 records of 10 ongoing studies, and listed 3 studies as awaiting classification. In total, we included 73 records of 41 studies (N = 194,035) in this systematic review. </p> <div class="figure" id="CD006887-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006887-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD006887-sec-0043"> <h4 class="title">Included studies</h4> <section id="CD006887-sec-0044"> <h5 class="title">Study design and location</h5> <p>Details of the methods, participants, intervention, comparison group, and outcome measures for each of the studies in this review are shown in the <a href="./references#CD006887-sec-0107" title="">Characteristics of included studies</a> table. We identified 23 individual‐level RCTs (N = 117,040), 17 cluster‐RCTs (N = 76,672), and 1 quasi‐RCT (N = 323). The earliest trial was reported in 1994 (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>), and the most recent was reported in 2016 (<a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>). Fifteen trials took place in European countries outside the UK (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0005" title="ChristensenB , EngbergM , LauritzenT . No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239-43. ">Christensen 2004</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0010" title="EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164:3354-60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice2002;51:546-52. LauritzenT , Leboeuf-YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice1995;45:542-7. ">Engberg 2002</a>; <a href="./references#CD006887-bbs2-0014" title="HanonO , FranconiG , MouradJJ , BaleydierA , CroceI , GirerdX . The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux2000;93(8):943-7. ">Hanon 2000</a>; <a href="./references#CD006887-bbs2-0015" title="HetlevikI , HolmenJ , KrugerO . Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care1999;17:35-40. ">Hetlevik 1999</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>); 12 trials in the USA (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>); 7 trials in the UK (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>); 3 trials in Canada (<a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0022" title="LowensteynI , JosephL , LevintonC , AbrahamowiczM , SteinertY , GroverS . Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine1998;27(5 Pt 1):730-7. ">Lowensteyn 1998</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>); 3 trials in Australia or New Zealand (<a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>); and 1 Internet‐based trial that did not report a specific country (<a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>). All studies were conducted in the outpatient setting. Participant follow‐up ranged from no follow‐up in <a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>, <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a> and <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a> to 10 years of extended follow‐up in <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>. In total, 21 out of 41 trials reported a follow‐up of one year or more. </p> </section> <section id="CD006887-sec-0045"> <h5 class="title">Participants</h5> <p>Mean age reported in the trials ranged from 40 years in <a href="./references#CD006887-bbs2-0010" title="EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164:3354-60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice2002;51:546-52. LauritzenT , Leboeuf-YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice1995;45:542-7. ">Engberg 2002</a> to 71 years in <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>, and the proportion of female participants ranged from 8% in <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a> to 80% in <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>. In the 20 trials that reported participants' ethnicity, most (16 out of 20) included a majority of white or European participants; the remaining 4 trials included a majority of African American participants (<a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>). Participants in the included trials had varying past medical histories. Ten trials included only participants with higher CVD risk (defined as diabetes mellitus or 10‐year CVD risk ≥ 10%) (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>), and 5 of these trials included only participants with diabetes mellitus (<a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>). The other 31 trials included participants with all risk levels. There were 13 trials that included participants with prevalent CVD, but based on our selection criteria we included only those trials where these participants made up &lt; 30% of the total sample (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>). One trial included participants with human immunodeficiency virus (HIV) who were part of the Swiss HIV Cohort Study (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>). </p> </section> <section id="CD006887-sec-0046"> <h5 class="title">Interventions and comparison groups</h5> <p>Interventions varied across trials, which featured different CVD risk scores, risk presentations, and co‐interventions (<a href="#CD006887-fig-0002">Figure 2</a>). The two most common CVD risk scores used were the Framingham Coronary Heart Disease Risk Score (24 trials) and the UK Prospective Diabetes Study (UKPDS) risk engine (6 trials). In these trials, baseline CVD risk was presented as a 5‐ or 10‐year absolute risk of a CVD event. Six trials used risk‐adjusted cardiovascular age (called by various names such as heart age, cardiovascular age, or vascular age) in addition to or in lieu of the absolute CVD risk information (<a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0022" title="LowensteynI , JosephL , LevintonC , AbrahamowiczM , SteinertY , GroverS . Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine1998;27(5 Pt 1):730-7. ">Lowensteyn 1998</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>). In addition to the risk message, interventions also included: patient education material (31 trials); clinician‐ or patient‐facing decision‐support tools (27 trials); nurse counselling (11 trials); academic detailing/continuing medical education (9 trials); electronic health record integration (10 trials); electronic or paper‐based reminders (7 trials); and audit and feedback (4 trials). A few trials implemented only one of these components (<a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0014" title="HanonO , FranconiG , MouradJJ , BaleydierA , CroceI , GirerdX . The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux2000;93(8):943-7. ">Hanon 2000</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>), while on the opposite side of the spectrum, there were five or more of these components (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; ; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). In total, among the 41 studies, 28 studies incorporated health IT for some aspect of the risk score intervention. The range of co‐interventions is summarised in <a href="#CD006887-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD006887-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Summary of CVD risk score interventions by included study. Abbreviations: CHD: coronary heart disease; CVD: cardiovascular disease; FRS: Framingham risk score; MI: myocardial infarction; RF: risk factors, RR: risk ratio; UKPDS: United Kingdom Prospective Diabetes Study" data-id="CD006887-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-02.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary of CVD risk score interventions by included study.<br/>Abbreviations: CHD: coronary heart disease; CVD: cardiovascular disease; FRS: Framingham risk score; MI: myocardial infarction; RF: risk factors, RR: risk ratio; UKPDS: United Kingdom Prospective Diabetes Study </p> </div> </div> </div> <p>Comparison groups were generally characterised as 'usual care' by study authors and did not include the systematic provision of CVD risk scores. Some studies described the addition of: passive guideline dissemination (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>), provision of risk factor levels alone (<a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>), continuing medical education for an unrelated topic (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>), and general health and risk factor information (<a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>). Comparison group descriptions are summarised in <a href="#CD006887-fig-0002">Figure 2</a>. </p> </section> <section id="CD006887-sec-0047"> <h5 class="title">Outcomes</h5> <p>Among the included trials, the most common primary outcome in 10 trials addressed a clinical care process measure such as risk factor screening, preventive treatment discussions, guideline adherence, or achievement of risk factor targets (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0022" title="LowensteynI , JosephL , LevintonC , AbrahamowiczM , SteinertY , GroverS . Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine1998;27(5 Pt 1):730-7. ">Lowensteyn 1998</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>). Other primary outcomes reported in the included studies were multivariable CVD risk in eight trials (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>), patient‐reported outcomes in seven trials (<a href="./references#CD006887-bbs2-0005" title="ChristensenB , EngbergM , LauritzenT . No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239-43. ">Christensen 2004</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>), CVD risk factor levels in six trials (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0014" title="HanonO , FranconiG , MouradJJ , BaleydierA , CroceI , GirerdX . The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux2000;93(8):943-7. ">Hanon 2000</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>), medication prescribing rates in four trials (<a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>), and health behaviours in three trials (<a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>). Only two trials reported CVD events as a primary outcome, but both reported being underpowered for this endpoint after completion of the study (<a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>). </p> </section> <section id="CD006887-sec-0048"> <h5 class="title">Study funding sources</h5> <p>We present detailed information on study funding sources in the <a href="./references#CD006887-sec-0107" title="">Characteristics of included studies</a> table. Five trials reported receiving study funding exclusively from pharmaceutical companies (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0022" title="LowensteynI , JosephL , LevintonC , AbrahamowiczM , SteinertY , GroverS . Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine1998;27(5 Pt 1):730-7. ">Lowensteyn 1998</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>). There were 19 trials that reported funding from public and/or federal government sources (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0015" title="HetlevikI , HolmenJ , KrugerO . Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care1999;17:35-40. ">Hetlevik 1999</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>), 7 trials that reported study funding from a combination of public and private sources (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0005" title="ChristensenB , EngbergM , LauritzenT . No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239-43. ">Christensen 2004</a>; <a href="./references#CD006887-bbs2-0010" title="EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164:3354-60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice2002;51:546-52. LauritzenT , Leboeuf-YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice1995;45:542-7. ">Engberg 2002</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>), and 3 trials with study funding from internal (usually hospital) sources (<a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>). Five trials did not report sources of study funding (<a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0014" title="HanonO , FranconiG , MouradJJ , BaleydierA , CroceI , GirerdX . The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux2000;93(8):943-7. ">Hanon 2000</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>). </p> </section> </section> <section id="CD006887-sec-0049"> <h4 class="title">Excluded studies</h4> <p>We excluded 94 records of 77 studies after full‐text review and 2 trial registry records. The most common reason for exclusion was that a risk score was not part of the intervention (41 trials). We excluded other studies because they provided CVD risk scores in all treatment groups without a usual care comparator group (16 trials), were not an RCT or quasi‐RCT (10 trials), did not study a primary prevention population (11 trials), or used clinical vignettes and hypothetical patients (1 trial). </p> <p>A complete list of excluded studies, along with the reason for exclusion of each study, is presented in the <a href="./references#CD006887-sec-0108" title="">Characteristics of excluded studies</a> table. </p> <section id="CD006887-sec-0050"> <h5 class="title">Studies awaiting classification</h5> <p>We identified three studies awaiting classification (<a href="./references#CD006887-bbs2-0121" title="AdamsonR , SourijH , RingA , PriceHC , HolmanRR . Adding value to the experience of attending a diabetes clinic appointment: Provision of personalised 10 year cardiovascular disease (CVD) risk estimates. Diabetic Medicine2013;30:194. ">Adamson 2013</a>; <a href="./references#CD006887-bbs2-0122" title="GrynS , HarB , DresserG . Evaluation of the effect of cardiovascular risk assessment on treatment compliance in hypertension. Journal of Clinical Hypertension2012;14. ">Gryn 2012</a>; <a href="./references#CD006887-bbs2-0123" title="RoachP , SahaC , MarreroDG . Communicating cardiovascular risk to Latinos with type 2 diabetes using a Spanish language-based multimedia program. Diabetes2012;61:A88. ">Roach 2012</a>). Two of these studies included participants with diabetes mellitus (<a href="./references#CD006887-bbs2-0121" title="AdamsonR , SourijH , RingA , PriceHC , HolmanRR . Adding value to the experience of attending a diabetes clinic appointment: Provision of personalised 10 year cardiovascular disease (CVD) risk estimates. Diabetic Medicine2013;30:194. ">Adamson 2013</a>; <a href="./references#CD006887-bbs2-0123" title="RoachP , SahaC , MarreroDG . Communicating cardiovascular risk to Latinos with type 2 diabetes using a Spanish language-based multimedia program. Diabetes2012;61:A88. ">Roach 2012</a>), and one included participants with hypertension (<a href="./references#CD006887-bbs2-0122" title="GrynS , HarB , DresserG . Evaluation of the effect of cardiovascular risk assessment on treatment compliance in hypertension. Journal of Clinical Hypertension2012;14. ">Gryn 2012</a>). All three studies reported having an intervention group that received a personalised CVD risk estimate, but the identified records were abstracts and did not provide sufficient details to determine eligibility for this systematic review. Authors of two of these studies reported preparing manuscripts (<a href="./references#CD006887-bbs2-0122" title="GrynS , HarB , DresserG . Evaluation of the effect of cardiovascular risk assessment on treatment compliance in hypertension. Journal of Clinical Hypertension2012;14. ">Gryn 2012</a>; <a href="./references#CD006887-bbs2-0123" title="RoachP , SahaC , MarreroDG . Communicating cardiovascular risk to Latinos with type 2 diabetes using a Spanish language-based multimedia program. Diabetes2012;61:A88. ">Roach 2012</a>). We present additional details of these studies in the <a href="./references#CD006887-sec-0109" title="">Characteristics of studies awaiting classification</a> table. </p> </section> <section id="CD006887-sec-0051"> <h5 class="title">Ongoing studies</h5> <p>We identified 11 reports of 10 ongoing studies. Three of these studies are taking place in Europe (<a href="./references#CD006887-bbs2-0124" title="BadenbroekIF , StolDM , NielenMM , HollanderM , KraaijenhagenRA , deWitGA , et al. Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care. BMC Family Practice2014;15:90. ">Badenbroek 2014</a>; <a href="./references#CD006887-bbs2-0125" title="De KoningHJ , van derAalstCM , vanAerdeMA , IjkemaR , vanBruggenR , OudkerkM . Design and recruitment of the ROBINSCA trial: Screening for cardiovascular disease. European Heart Journal2015;36:985. IjkemaR , Van Aerde MA , Van Der Aalst CM , Van BallegooijenM , OudkerkM , De Koning HJ . A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment and coronary artery calcium: The ROBINSCA study. European Journal of Preventive Cardiology2014;21:S21. ">Ijkema 2014</a>; <a href="./references#CD006887-bbs2-0126" title="MaindalHT , StovringH , SandbaekA . Effectiveness of the population-based Check your health preventive programme conducted in primary care with 4 years follow-up [the CORE trial]: study protocol for a randomised controlled trial. Trials2014;15:341. ">Maindal 2014</a>), one in the USA (<a href="./references#CD006887-bbs2-0132" title="SanghaviDM , ConwayPH . Paying for Prevention: A Novel Test of Medicare Value-Based Payment for Cardiovasculr Risk Reduction. JAMA2015;314(2):123-124. ">Sanghavi 2015</a>), one in Canada (<a href="./references#CD006887-bbs2-0127" title="NCT00694239. Risk assessment and treat compliance in hypertension education trial (RATCHET) [Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension]. clinicaltrials.gov/ct2/show/NCT00694239 (first received 6 June 2008). ">NCT00694239</a>), one in the UK (<a href="./references#CD006887-bbs2-0133" title="SilarovaB , LucasJ , ButterworthAS , Di AngelantonioE , GirlingC , LawrenceK , et al. Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour. BMC Public Health2015;15:868. ">Silarova 2015</a>), one in Australia (<a href="./references#CD006887-bbs2-0131" title="RedfernJ , UsherwoodT , HarrisMF , RodgersA , HaymanN , PanarettoK , et al. A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol. BMJ Open2014;4:e004523. ">Redfern 2014</a>), and three in low‐ and middle‐income countries (<a href="./references#CD006887-bbs2-0128" title="NCT02096887. Effect of patient education on compliance and cardiovascular risk parameters (FAILAKA) [Effect of Patient Awareness and Education on Compliance and Cardiovascular Risk Factor Control]. clinicaltrials.gov/ct2/show/NCT02096887 (First received 24 March 2014). ">NCT02096887</a>; <a href="./references#CD006887-bbs2-0129" title="OgedegbeG , Plange-RhuleJ , GyamfiJ , ChaplinW , NtimM , ApusigaK , et al. A cluster-randomized trial of task shifting and blood pressure control in Ghana: study protocol. Implementation Science2014;9:73. ">Ogedegbe 2014</a>; <a href="./references#CD006887-bbs2-0130" title="PraveenD , PatelA , McMahonS , PrabhakaranD , CliffordGD , MaulikPK , et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science2013;8(1):137. ">Praveen 2013</a>). Two studies will supplement CVD risk scores with novel sources of CVD risk information: <a href="./references#CD006887-bbs2-0125" title="De KoningHJ , van derAalstCM , vanAerdeMA , IjkemaR , vanBruggenR , OudkerkM . Design and recruitment of the ROBINSCA trial: Screening for cardiovascular disease. European Heart Journal2015;36:985. IjkemaR , Van Aerde MA , Van Der Aalst CM , Van BallegooijenM , OudkerkM , De Koning HJ . A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment and coronary artery calcium: The ROBINSCA study. European Journal of Preventive Cardiology2014;21:S21. ">Ijkema 2014</a> with coronary artery calcium scores and <a href="./references#CD006887-bbs2-0133" title="SilarovaB , LucasJ , ButterworthAS , Di AngelantonioE , GirlingC , LawrenceK , et al. Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour. BMC Public Health2015;15:868. ">Silarova 2015</a> with genetic risk information. Three ongoing studies will test innovative implementation models to provide CVD risk scores. These include: direct‐to‐patient health portals within an electronic health record (<a href="./references#CD006887-bbs2-0131" title="RedfernJ , UsherwoodT , HarrisMF , RodgersA , HaymanN , PanarettoK , et al. A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol. BMJ Open2014;4:e004523. ">Redfern 2014</a>), non‐physician healthcare workers in resource‐poor settings (<a href="./references#CD006887-bbs2-0130" title="PraveenD , PatelA , McMahonS , PrabhakaranD , CliffordGD , MaulikPK , et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science2013;8(1):137. ">Praveen 2013</a>), and financial incentives linked to CVD risk assessment and absolute risk reduction (<a href="./references#CD006887-bbs2-0132" title="SanghaviDM , ConwayPH . Paying for Prevention: A Novel Test of Medicare Value-Based Payment for Cardiovasculr Risk Reduction. JAMA2015;314(2):123-124. ">Sanghavi 2015</a>). The <a href="./references#CD006887-sec-0110" title="">Characteristics of ongoing studies</a> table presents details of these studies. </p> </section> </section> </section> <section id="CD006887-sec-0052"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall and trial‐specific assessment of risk of bias are shown in <a href="#CD006887-fig-0003">Figure 3</a> and <a href="#CD006887-fig-0004">Figure 4</a>. In general, there was high risk of bias across the included studies. Due to the nature of the intervention, few trials were able to blind participants, study personnel, or both. Thus, in our overall risk of bias assessment, we put greater weight on blinding of outcome assessment (detection bias) compared to blinding of participants or study personnel (performance bias). We concluded that only three trials had an overall low risk of bias across most domains (<a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>). We summarise risk of bias assessment across each domain below, but detailed documentation supporting risk of bias assessment for each trial is included in the <a href="./references#CD006887-sec-0107" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD006887-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006887-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD006887-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006887-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD006887-sec-0053"> <h4 class="title">Allocation</h4> <p>There were 19 trials that adequately reported the methods used for random sequence generation, and we assessed them as being at low risk of bias (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0027" title="Perestelo-PerezL , Rivero-SantanaA , BoronatM , Sanchez-AfonsoJA , Perez-RamosJ , MontoriVM , et al. Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: a randomized trial. Patient Education and Counseling2016;99(2):295-9. ">Perestelo‐Perez 2016</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). We assessed 19 trials as being at unclear risk of bias and 3 trials as having an inadequate method of random sequence generation. </p> <p>Sixteen trials reported adequate allocation concealment (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0010" title="EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164:3354-60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice2002;51:546-52. LauritzenT , Leboeuf-YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice1995;45:542-7. ">Engberg 2002</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>). Among the remaining trials, there were 18 at unclear risk of bias and 7 trials at high risk of bias for allocation concealment. </p> <p>In total, 12 trials were assessed as being at low risk of selection bias, that is, for both random sequence generation and allocation concealment (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>). </p> </section> <section id="CD006887-sec-0054"> <h4 class="title">Blinding</h4> <p>Due to the nature of the intervention, we assessed 38 out of 41 trials as being at high risk of bias due to an unblinded study design. The trials with low or unclear risk of bias were Internet‐based studies where research personnel had no direct contact with participants (<a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>). Therefore, we used blinding of outcome assessors to determine overall risk of bias. Among the 41 trials, 12 trials reported adequate blinding of outcome assessors (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>; <a href="./references#CD006887-bbs2-0035" title="VagholkarS , ZwarN , JayasingheUW , Denney-WilsonE , PatelA , CampbellT , et al. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. American Heart Journal2014;167(1):28-35. WanQ , HarrisMF , ZwarN , CampbellT , PatelA , VagholkarS , et al. Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. American Heart Journal2009;157:436-41. ">Vagholkar 2014</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). The remaining 18 trials were at unclear risk of bias, and 11 trials were at high risk of bias due to unblinded outcome assessors. </p> </section> <section id="CD006887-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>Many studies suffered from high losses to follow‐up and missing data, particularly data used for calculating follow‐up cholesterol levels or risk scores. Moreover, few studies performed intention‐to‐treat analyses. Only 13 trials adequately addressed incomplete data (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0012" title="HallLM , JungRT , LeeseGP . Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ2003;326:251-2. ">Hall 2003</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). We assessed 8 trials as being at unclear risk of bias and 20 trials as being at high risk of bias due to incomplete outcome data. </p> </section> <section id="CD006887-sec-0056"> <h4 class="title">Selective reporting</h4> <p>Several of the included studies either had protocols available for review or were prospectively registered. The risk of bias associated with selective reporting was low in 15 trials (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>), unclear in 18 trials, and high in 8 trials. </p> </section> <section id="CD006887-sec-0057"> <h4 class="title">Other potential sources of bias</h4> <p>Other potential sources of bias are reviewed in detail in the <a href="./references#CD006887-sec-0107" title="">Characteristics of included studies</a> table. Common sources of potential bias included: pharmaceutical funding or potential financial conflicts of interest among study authors (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0010" title="EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . Can systematic general health checks and health discussions improve the cardiovascular risk profile in the population?: A randomized and controlled study in general practice with five years follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulaere risikoprofil i befolkningen?: En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger2002;164:3354-60. EngbergM , ChristensenB , KarlsmoseB , LousJ , LauritzenT . General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. Journal of Family Practice2002;51:546-52. LauritzenT , Leboeuf-YdeC , LundeIM , NielsenKD . Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. British Journal of General Practice1995;45:542-7. ">Engberg 2002</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0022" title="LowensteynI , JosephL , LevintonC , AbrahamowiczM , SteinertY , GroverS . Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS). Preventive Medicine1998;27(5 Pt 1):730-7. ">Lowensteyn 1998</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0039" title="WilliamsGC , McGregorH , SharpD , KouidesRW , LevesqueCS , RyanRM , et al. A self-determination multiple risk intervention trial to improve smokers' health. Journal of General Internal Medicine2006;21:1288-94. WilliamsGC , MinicucciDS , KouidesRW , LevesqueCS , ChirkovVI , RyanRM , et al. Self-determination, smoking, diet and health. Health Education Research2002;17(5):512-21. ">Williams 2006</a>); contamination bias (<a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0029" title="PersellSD , BrownT , LeeJY , ShahS , HenleyE , LongT , et al. Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8(6):560-6. PersellSD , ShahS , BrownT , LeeJY , SanchezT , KnightRG , et al. Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: a randomized controlled trial. Circulation2014;130:A14008. ShahS , BrownT , LeeJY , Jean-JacquesM , KandulaNR , PersellSD . Individualized risk communication and lay outreach for the primary prevention of cardiovascular disease in community health centers: preliminary results of a randomized controlled trial. Journal of General Internal Medicine2014;29:S126. ">Persell 2015</a>; <a href="./references#CD006887-bbs2-0031" title="SheridanSL , ShadleJ , Simpson RJ Jr, PignoneMP . The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Services Research2006;6:121. ">Sheridan 2006</a>; <a href="./references#CD006887-bbs2-0032" title="SheridanSL , DraegerLB , PignoneMP , KeyserlingTC , Simpson RJ Jr, RimerB , et al. A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Services Research2011;11:331. SheridanSL , DraegerLB , PignoneMP , RimerB , BangdiwalaSI , CaiJ , et al. The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Medical Informatics and Decision Making2014;14:14. ">Sheridan 2011</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>); and poor fidelity to the intervention protocol (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0008" title="EatonCB , ParkerDR , BorkanJ , McMurrayJ , RobertsMB , LuB , et al. Translating cholesterol guidelines into primary care practice: a multimodal cluster randomized trial. Annals of Family Medicine2011;9(6):528-37. ">Eaton 2011</a>; <a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>). </p> </section> </section> <section id="CD006887-sec-0058"> <h3 class="title" id="CD006887-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD006887-tbl-0001"><b>Summary of findings 1</b> CVD risk scoring for the primary prevention of cardiovascular disease</a> </p> <p>See: Summary of findings for the main outcomes (<a href="./full#CD006887-tbl-0001">summary of findings Table 1</a>). </p> <section id="CD006887-sec-0059"> <h4 class="title">Primary outcomes</h4> <section id="CD006887-sec-0060"> <h5 class="title">Cardiovascular disease events</h5> <p>We identified only three RCTs (N = 99,070) that reported the effects of providing CVD risk scores on CVD events (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>). Among participants in the CVD risk score group, there was low‐quality evidence suggesting little or no effect on CVD events compared with usual care (5.4% versus 5.3%; RR 1.01, 95% CI 0.95 to 1.08; I² = 25%; <a href="./references#CD006887-fig-0008" title="">Analysis 1.1</a>). Notably, study authors from two of these trials reported being underpowered for this endpoint because of limited recruitment of participants over the age of 50 and low CVD event rates (<a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>). The third trial was in a cohort of people with HIV in Switzerland (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>). Due to the unique characteristics and limited generalisability of this cohort, we reanalysed data excluding this study; results were unchanged in direction and magnitude (<a href="./references#CD006887-fig-0009" title="">Analysis 1.2</a>). </p> </section> <section id="CD006887-sec-0061"> <h5 class="title">Cholesterol level</h5> <p>Effects of providing CVD risk scores on cholesterol levels were reported for total cholesterol and LDL cholesterol. We identified 12 RCTs (N = 20,437) that reported the effects of providing CVD risk scores on total cholesterol and were included in the meta‐analysis. There was low‐quality evidence suggesting that providing CVD risk scores may slightly reduce total cholesterol levels compared with usual care (MD −0.10 mmol/L, 95% CI −0.20 to 0.00; I² = 94%; <a href="./references#CD006887-fig-0010" title="">Analysis 1.3</a>). We also identified 10 RCTs (N = 22,122) that reported on the effects of providing CVD risk scores on LDL cholesterol levels. There was uncertainty about the effect of providing CVD risk scores compared with usual care on LDL cholesterol levels (MD −0.03 mmol/L, 95% CI −0.10 to 0.04; I² = 84%; low‐quality evidence; <a href="./references#CD006887-fig-0011" title="">Analysis 1.4</a>); the results were imprecise but similar in direction and magnitude to those for total cholesterol. There was substantial heterogeneity for both outcomes that was not explained by a single trial, so these effect estimates should be interpreted with caution. There was no evidence of publication bias by funnel plot for total cholesterol level (<a href="#CD006887-fig-0005">Figure 5</a>). Many of the trials identified in this review reported on achievement of guideline‐recommended cholesterol goals after provision of a CVD risk score. However, this outcome was deemed to be unsuitable for meta‐analysis due to the marked variation in cholesterol goals from different countries, guidelines, and time periods. One pragmatic clinical trial (N = 435) did not use systematic follow‐up procedures after providing CVD risk scores but reported that participants in the CVD risk score group had a greater proportion of repeat LDL cholesterol levels &gt; 30 mg/dL lower than baseline compared with those in the usual care group (22.5% vs. 16.1%, OR 1.59, 95% CI 1.05 to 2.41, P  =  0.029; <a href="./references#CD006887-bbs2-0028" title="PersellSD , Lloyd-JonesDM , FriesemaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2013;28(4):554-60. PersellSD , Lloyd-JonesDM , FriesmaEM , CooperAJ , BakerDW . Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial. Journal of General Internal Medicine2012;27:S181-2. ">Persell 2013</a>). </p> <div class="figure" id="CD006887-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.3 Total cholesterol (mmol/L)." data-id="CD006887-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.3 Total cholesterol (mmol/L). </p> </div> </div> </div> </section> <section id="CD006887-sec-0062"> <h5 class="title">Blood pressure level</h5> <p>Trials reported the effects of providing CVD risk scores on blood pressure levels for systolic blood pressure, diastolic blood pressure, or both. We identified low‐quality evidence suggesting that providing CVD risk scores may slightly reduce systolic blood pressure compared with usual care (MD −2.77 mmHg, 95% CI −4.16 to −1.38; I² = 93%; 16 trials, N = 32,954; <a href="./references#CD006887-fig-0012" title="">Analysis 1.5</a>). Similarly, we found low‐quality evidence suggesting that providing CVD risk scores may slightly reduce diastolic blood pressure compared with usual care (MD −1.12 mmHg, 95% CI −2.11 to −0.13; I² = 94%; 14 trials, N = 22,378; <a href="./references#CD006887-fig-0013" title="">Analysis 1.6</a>). There was substantial heterogeneity for both outcomes that was not explained by a single trial, so readers should interpret these estimates with caution. There was no evidence of publication bias by funnel plot for systolic blood pressure (<a href="#CD006887-fig-0006">Figure 6</a>). Of note, there were two RCTs that reported the effects of providing CVD risk scores on systolic and diastolic blood pressures, but we did not pool them because of insufficient data (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0014" title="HanonO , FranconiG , MouradJJ , BaleydierA , CroceI , GirerdX . The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension [L'estimation du risque cardiovasculaire chez des patients hypertendus ne modifie pas la prise en charge de l'HTA]. Archives des Maladies du Coeur et des Vaisseaux2000;93(8):943-7. ">Hanon 2000</a>). Neither trial found a difference in blood pressure level between the CVD risk score versus usual care groups. </p> <div class="figure" id="CD006887-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.5 Systolic blood pressure (mmHg)." data-id="CD006887-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.5 Systolic blood pressure (mmHg). </p> </div> </div> </div> </section> <section id="CD006887-sec-0063"> <h5 class="title">Multivariable CVD risk</h5> <p>In total, 17 RCTs (N = 29,119) reported on the effects of providing CVD risk scores on multivariable CVD risk (a summary measure that incorporated changes in multiple different CVD risk factor levels simultaneously). The scale of this measure varied among studies. Moreover, some studies compared final values between the two treatment groups while others compared change from baseline values. We elected to calculate standardised mean differences (SMDs) for change from baseline values for the CVD risk score group and the usual care comparator for our main outcomes. We identified low‐quality evidence suggesting that providing CVD risk scores may slightly reduce multivariable CVD risk compared with usual care (SMD −0.21, 95% CI −0.39 to −0.02; I² = 94%; 9 trials, N = 9549; <a href="./references#CD006887-fig-0014" title="">Analysis 1.7</a>). There was substantial heterogeneity that was not explained by a single trial, so readers should interpret these estimates with caution. There was no evidence of publication bias by funnel plot (<a href="#CD006887-fig-0007">Figure 7</a>). We also meta‐analysed studies that compared final values for multivariable CVD risk estimates between the intervention and comparison groups and observed similar findings (SMD −0.15, 95% CI −0.25 to −0.06; <a href="./references#CD006887-fig-0039" title="">Analysis 5.1</a>). </p> <div class="figure" id="CD006887-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.7 Change in multivariable CVD risk." data-id="CD006887-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.7 Change in multivariable CVD risk. </p> </div> </div> </div> <p>Five trials reported the effects of the intervention on multivariable CVD risk, but we did not pool these in the meta‐analyses because of how they reported data (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>, <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0015" title="HetlevikI , HolmenJ , KrugerO . Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care1999;17:35-40. ">Hetlevik 1999</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>). One of these trials demonstrated a reduction in multivariable CVD risk with the provision of a CVD risk score (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>). This cluster‐RCT randomised 12,472 men and women in 13 towns in Britain to a nurse‐led screening and counselling programme based on Dundee score (a measure of coronary heart disease risk) or usual care. After one year, the intervention reduced the Dundee risk score by 16.1% (95% CI 10.9% to 21.1%) in men and 15.7% (95% CI 7.4% to 23.3%) in women compared with usual care. The other four studies (N = 6626), however, did not find that provision of a CVD risk score changed multivariable CVD risk (<a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a>; <a href="./references#CD006887-bbs2-0015" title="HetlevikI , HolmenJ , KrugerO . Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care1999;17:35-40. ">Hetlevik 1999</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>). </p> </section> <section id="CD006887-sec-0064"> <h5 class="title">Adverse events</h5> <p>There were four RCTs (N = 4630) that reported on adverse events after providing a CVD risk score (<a href="./references#CD006887-bbs2-0001" title="BennerJS , CherrySB , ErhardtL , FernandesM , FlammerM , GaciongZ , et al. Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials2007;28:662-73. BennerJS , ErhardtL , FlammerM , MollerRA , RajicicN , ChangelaK , et al. A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. International Journal of Clinical Practice2008;62:1484-98. ">Benner 2008</a>; <a href="./references#CD006887-bbs2-0011" title="GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. Journal of General Internal Medicine2009;24:33-9. GroverSA , LowensteynI , JosephL , KaouacheM , MarchandS , CoupalL , et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy - The CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine2007;167:2296-303. ">Grover 2007</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0034" title="TurnerBJ , HollenbeakCS , LiangY , PanditK , JosephS , WeinerMG . A randomized trial of peer coach and office staff support to reduce coronary heart disease risk in African-Americans with uncontrolled hypertension. Journal General Internal Medicine2012;27:1258-64. ">Turner 2012</a>). Definition of adverse events varied between studies and included back pain, headache, cough, upper respiratory infection, musculoskeletal pain, and anxiety. There was low‐quality evidence suggesting that providing a CVD risk score may reduce adverse events compared with usual care, but the results were imprecise (1.9% versus 2.7%; RR 0.72, 95% CI 0.49 to 1.04; I² = 0%; <a href="./references#CD006887-fig-0015" title="">Analysis 1.8</a>). There were three RCTs (N = 968) that specifically reported on the effect of the CVD risk scores on anxiety (<a href="./references#CD006887-bbs2-0024" title="FaheyT , MontgomeryAA , PetersTJ . Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Services Research2001;1:10. MontgomeryAA , FaheyT , PetersTJ , MacIntoshC , SharpDJ . Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ2000;320:686-90. ">Montgomery 2000</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0038" title="WelschenLM , BotSD , DekkerJM , TimmermansDR , WeijdenT , NijpelsG . The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health2010;10:457. WelschenLM , BotSD , KostensePJ , DekkerJM , TimmermansDR , van derWeijdenT , et al. Effects of cardiovascular disease risk communication for patients with type 2 diabetes on risk perception in a randomized controlled trial: the @RISK study. Diabetes Care2012;35:2485-92. WelschenLMC , BotSDM , van derWeijdenT , TimmermansDRM , DekkerJM , NijpelsG . Cardiovascular disease risk communication for patients with type 2 diabetes: the @RISK study. Diabetologia2010;53:S487. ">Welschen 2012</a>). Two measured anxiety as a continuous variable and observed that providing CVD risk scores may have little to no effect on anxiety compared with usual care (SMD −0.07, 95% CI −0.27 to 0.13; I² = 0%; 2 studies, N = 388; low‐quality evidence; <a href="./references#CD006887-fig-0016" title="">Analysis 1.9</a>). We did not include <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a> in meta‐analysis due to insufficient reporting of data but observed no difference in the proportion of anxious participants who received a CVD score versus usual care (16% vs 16%, P value not provided). Lastly, one trial measured psychological distress in middle‐aged participants who received a CVD risk assessment (with or without primary care physician follow‐up) compared with usual care (<a href="./references#CD006887-bbs2-0005" title="ChristensenB , EngbergM , LauritzenT . No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation2004;11(3):239-43. ">Christensen 2004</a>). This trial found no difference in psychological distress at one and five years between participants in the two treatment groups that received a CVD risk assessment compared with those in the usual care group (P = 0.466 at one year and P = 0.579 at five years). </p> </section> </section> <section id="CD006887-sec-0065"> <h4 class="title">Secondary outcomes</h4> <section id="CD006887-sec-0066"> <h5 class="title">Medication prescriptions in higher risk individuals</h5> <section id="CD006887-sec-0067"> <h6 class="title">New or intensified lipid‐lowering medications</h6> <p>We identified low‐quality evidence suggesting that providing CVD risk scores may increase prescriptions for new or intensified lipid‐lowering medications in higher risk people compared with usual care (15.7% versus 10.7%; RR 1.47, 95% CI 1.15 to 1.87; I² = 40%; 11 trials, N = 14,175; <a href="./references#CD006887-fig-0017" title="">Analysis 1.10</a>). There was substantial heterogeneity among studies that was not explained by a single trial, so readers should interpret these estimates with caution. </p> <p>Four additional studies reported the effects of providing a CVD risk score on lipid‐lowering medication prescribing compared with usual care, but we did not include them in the meta‐analysis because they did not report sufficient data to determine which higher‐risk participants received a lipid‐lowering medication (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>; <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>). None of these studies reported a change in lipid‐lowering medication prescribing. In <a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>, use of a CVD risk score‐based decision support tool increased "guideline‐concordant lipid‐lowering therapy" compared with passive dissemination of an unrelated guideline (9.7%, 95% CI 2.8% to 16.6%), but this was primarily driven by a reduction in inappropriate prescribing in lower risk individuals. Authors reported no difference in appropriate lipid‐lowering medication prescribing rates (P = 0.37) (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>). Similarly, in <a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>, a computerised decision‐support tool that provided a personalised CVD risk score decreased inappropriate statin prescribing (primarily in lower risk individuals) but did not increase guideline‐recommended statin prescribing compared with usual care. In <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>, the authors reported no difference in the proportion of participants with CVD risk &gt;15% who were treated with preventive medications between the CVD risk score group and the usual care comparator but formal statistical testing was not presented. Lastly, in <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>, there was no difference in new or increased lipid‐lowering medication prescribing in a group of Australian adults randomised to a web‐based decision support tool (percent difference −1.6%, 95% CI −3.57 to 0.57, P = 0.15), but insufficient data were available to determine risk status of participants who received therapy. </p> </section> <section id="CD006887-sec-0068"> <h6 class="title">New or intensified antihypertensive medications</h6> <p>We identified low‐quality evidence that providing CVD risk scores may increase new or intensified antihypertensive medications compared with usual care (17.2% versus 11.4%; RR 1.51, 95% CI 1.08 to 2.11, I² = 53%; 8 studies, N = 13,255; <a href="./references#CD006887-fig-0018" title="">Analysis 1.11</a>). There was substantial heterogeneity among studies that was not explained by a single trial, so readers should interpret these estimates with caution. We did not pool three studies reporting the effects of providing CVD risk scores on antihypertensive medication prescribing in the meta‐analysis because they did not provide sufficient information to determine which high‐risk participants were prescribed antihypertensive medications. None of these studies reported a difference in antihypertensive medication prescribing between the two groups (<a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>; <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>). </p> </section> <section id="CD006887-sec-0069"> <h6 class="title">New aspirin prescriptions</h6> <p>Providing CVD risk scores may increase new aspirin prescribing compared with usual care (RR 2.71, 95% CI 1.24 to 5.91, I² = 0%; 3 studies, N = 1614; <a href="./references#CD006887-fig-0019" title="">Analysis 1.12</a>). We did not pool three additional studies reporting the effect of providing CVD risk scores on aspirin prescribing in the meta‐analysis because it was unclear which participants were at higher risk (<a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>), and the trials did not provide data on primary prevention (<a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>). Two of these studies reported no difference in aspirin prescribing in the overall study population (<a href="./references#CD006887-bbs2-0017" title="JacobsonTA , GutkinSW , HarperCR . Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment ViaTotal Risk (AVIATOR) study. Current Medical Research and Opinion2006;22:1065-73. ">Jacobson 2006</a>; <a href="./references#CD006887-bbs2-0020" title="KellerH , KronesT , BeckerA , HirschO , SonnichsenAC , PopertU , et al. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice. European Journal of Preventive Cardiology2012;19(3):322-9. KronesT , KellerH , SonnichsenA , SadowskiEM , BaumE , WegscheiderK , et al. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine2008;6:218-27. ">Krones 2008</a>). The other study reported an increase in aspirin prescribing among participants with prevalent CVD (17.8% vs 2.7%; RR 4.79, 95% CI 2.47 to 9.29), but this did not meet the primary prevention focus of this review (<a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>). </p> </section> </section> <section id="CD006887-sec-0070"> <h5 class="title">Medication adherence</h5> <p>There was uncertainty whether providing CVD risk scores had an effect on medication adherence compared with usual care (RR 1.14, 95% CI 0.92 to 1.41, I² = 58%; 4 studies, N = 621; <a href="./references#CD006887-fig-0020" title="">Analysis 1.13</a>). One additional study (N = 150) reported "no difference" in medication adherence rates between participants randomised to a statin decision support tool but did not provide specific estimates or statistical testing (<a href="./references#CD006887-bbs2-0023" title="MannDM , PoniemanD , MontoriVM , ArciniegaJ , McGinnT . The Statin Choice decision aid in primary care: a randomized trial. Patient Education and Counseling2010;80:138-140. ">Mann 2010</a>). </p> </section> <section id="CD006887-sec-0071"> <h5 class="title">Health behaviours</h5> <section id="CD006887-sec-0072"> <h6 class="title">Smoking</h6> <p>Providing a CVD risk score may increase smoking cessation compared with usual care (RR 1.38, 95% CI 1.13 to 1.69, I² = 0%; 7 studies, N = 5346; <a href="./references#CD006887-fig-0021" title="">Analysis 1.14</a>). There were nine additional studies that reported on the effects of providing CVD risk scores on the prevalence of smoking rates, and results were mixed. Five of these studies reported reductions in smoking prevalence in the CVD risk score group compared with the usual care group (<a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a>; <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>), whereas four studies reported no change in smoking prevalence in the CVD risk score group compared with usual care (<a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>; <a href="./references#CD006887-bbs2-0015" title="HetlevikI , HolmenJ , KrugerO . Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scandinavian Journal of Primary Health Care1999;17:35-40. ">Hetlevik 1999</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0041" title="ZulligLL , SandersLL , ShawRJ , McCantF , DanusS , BosworthHB . A randomised controlled trial of providing personalised cardiovascular risk information to modify health behaviour. Journal of Telemedicine and Telecare2014;20:147-52. ">Zullig 2014</a>). In the only study to biochemically verify smoking status, there was no difference in urine cotinine for participants who received a CVD risk score compared with usual care (SMD −0.53, 95% CI −1.23 to 0.17, P = 0.136; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>). </p> </section> <section id="CD006887-sec-0073"> <h6 class="title">Exercise</h6> <p>There were eight RCTs (N = 8391) that reported the effects of providing CVD risk scores on physical activity (<a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>; <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). Physical activity outcomes varied by studies and included: self‐reported increase in physical activity, number of days exercising &gt; 30 minutes, and proportion meeting physical activity guidelines. Two studies (N = 2595) measured self‐reported increase in physical activity, and demonstrated no evidence that providing a CVD risk score had an effect on this outcome compared with usual care (RR 0.98, 95% CI 0.90 to 1.06, I² = 0%; <a href="./references#CD006887-fig-0022" title="">Analysis 1.15</a>). The remaining 6 RCTs reported mixed results on physical activity. One RCT of 154 participants reported an increase in the number of days with physical activity &gt; 30 minutes (3.7 days in intervention versus 2.4 days in control; P = 0.002; <a href="./references#CD006887-bbs2-0009" title="EdelmanD , OddoneEZ , LiebowitzRS , Yancy WS Jr, OlsenMK , JeffreysAS , et al. A multidimensional integrative medicine intervention to improve cardiovascular risk. Journal of General Internal Medicine2006;21(7):728-34. ">Edelman 2006</a>). Similarly, <a href="./references#CD006887-bbs2-0021" title="Lopez-GonzalezAA , AguiloA , FronteraM , Bennasar-VenyM , CamposI , Vicente-HerreroT , et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. European Journal of Preventive Cardiology2015;22(3):389-96. ">Lopez‐Gonzalez 2015</a> reported an increase in self‐reported exercise sessions per week in participants receiving a Framingham risk message compared with usual care: 3.48 sessions (95% CI 3.35 to 3.62) in the Framingham risk message group versus 3.60 sessions (95% CI 3.47 to 3.73) in the usual care group. In <a href="./references#CD006887-bbs2-0036" title="Van SteenkisteB , van derWeijdenT , StoffersHE , KesterAD , TimmermansDR , GrolR . Improving cardiovascular risk management: a randomized, controlled trial on the effect of a decision support tool for patients and physicians. European Journal of Prevention and Rehabilitation2007;14:44-50. Van SteenkisteB , van derWeijdenTM , StoffersJH , GrolRP . Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care 1498. Patient Education and Counseling2008;72(1):63-70. ">Van Steenkiste 2007</a>, authors reported an increase in within‐group physical activity among participants receiving a CVD risk score compared with usual care, but there were marked baseline imbalances between the two treatment groups and follow‐up data were missing from &gt;50% of participants. In contrast, there was no change in physical activity in the CVD risk score group compared with usual care in two RCTs involving 930 participants (<a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). Only one RCT (N = 198) used an objective measure of physical activity with an accelerometer and showed no difference in total accelerometer counts between those in the CVD risk score group and those in the usual care group (SMD 0.086, 95% CI −0.202 to 0.374, P = 0.559; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>). </p> </section> <section id="CD006887-sec-0074"> <h6 class="title">Diet</h6> <p>There were six RCTs (N = 5375) that reported information on the effects of providing CVD risk scores on diet (<a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). Measures of diet were highly variable with little overlap, so we did not perform quantitative meta‐analysis. Results varied among studies. Two studies reported improvements in heart‐healthy diets after providing a CVD risk score (<a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>; <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a>). In <a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>, self‐reported increase in fruit and vegetable consumption (24.3% versus 11.6%, P &lt; 0.001) and self‐reported reduction in fat consumption (30.0% versus 9.4%, P &lt; 0.001) was greater in the CVD risk score group compared with usual care (<a href="./references#CD006887-bbs2-0013" title="HanlonP , McEwenJ , CareyL , GilmourH , TannahillC , TannahillA , et al. Health checks and coronary risk: further evidence from a randomised controlled trial. BMJ1995;311:1609-13. ">Hanlon 1995</a>). Similarly, in <a href="./references#CD006887-bbs2-0040" title="WisterA , LoewenN , Kennedy-SymondsH , McGowanB , McCoyB , SingerJ . One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. Canadian Medical Association Journal2007;177(8):859-65. ">Wister 2007</a> nutritional level (as measured by a 5‐point ordinal scale based on the number of recommended food groups met per day)was higher in the CVD risk score group compared with the usual care group (0.30, 95% CI 0.13 to 0.47 versus −0.05, 95% CI −0.22 to 0.12; p &lt;0.01; units not provided). In contrast, four studies reported no difference in healthy dietary patterns between the two groups (<a href="./references#CD006887-bbs2-0019" title="Koelewijn-van LoonMS , van derWeijdenT , RondaG , vanSteenkisteB , WinkensB , ElwynG , et al. Improving lifestyle and risk perception through patient involvement in nurse-led cardiovascular risk management: a cluster-randomized controlled trial in primary care. Preventive Medicine2010;50(1-2):35-44. Koelewijn-van LoonMS , van derWeijdenT , vanSteenkisteB , RondaG , WinkensB , SeverensJL , et al. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Canadian Medical Association Journal2009;181(12):E267-E274. Koelewijn-van LoonMS , vanSteenkisteB , RondaG , WensingM , StoffersHE , ElwynG , et al. Improving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care [protocol]. BMC Health Services Research2008;8:9. ">Koelewijn‐van Loon 2010</a>; <a href="./references#CD006887-bbs2-0030" title="PriceHC , GriffinSJ , HolmanRR . Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trial. Diabetic Medicine2011;28(3):363-72. PriceHC , TuckerL , GriffinSJ , HolmanRR . The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 x 2 factorial understanding risk trial. Cardiovascular Diabetology2008;7:21. ">Price 2011</a>; <a href="./references#CD006887-bbs2-0033" title="SouretiA , MurrayP , CobainM , vanMechelenW , HurlingR . Web-based risk communication and planning in an obese population: exploratory study. Journal of Medical Internet Research2011;13:e100. ">Soureti 2011</a>; <a href="./references#CD006887-bbs2-0037" title="WebsterR , Li SCh, SullivanDR , JayneK , SuSY , NealB . Effects of internet-based tailored advice on the use of cholesterol-lowering interventions: a randomized controlled trial. Journal of Medical Internet Research2010;12(3):e42. ">Webster 2010</a>). </p> </section> <section id="CD006887-sec-0075"> <h6 class="title">Decisional conflict</h6> <p>We identified evidence suggesting that providing a CVD risk score may reduce decisional conflict compared with usual care (SMD −0.29, 95% CI −0.57 to −0.01, I² = 79%; 4 studies, N = 1261; <a href="./references#CD006887-fig-0023" title="">Analysis 1.16</a>). The effect estimate had substantial heterogeneity that was explained by <a href="./references#CD006887-bbs2-0025" title="EmmettCL , MontgomeryAA , PetersTJ , FaheyT . Three-year follow-up of a factorial randomised controlled trial of two decision aids for newly diagnosed hypertensive patients. British Journal of General Practice2005;55:551-3. MontgomeryAA , FaheyT , PetersTJ . A factorial randomised controlled trial of decision analysis and an information video plus leaflet for newly diagnosed hypertensive patients. British Journal of General Practice2003;53:446-53. ">Montgomery 2003</a>, the study with the largest magnitude reduction in decisional conflict. The direction of the effect was similar, but the magnitude was attenuated when excluding this trial from the analysis (SMD −0.16, 95% CI −0.28 to −0.04, I² = 0%; 3 studies, N = 1049 participants). </p> </section> <section id="CD006887-sec-0076"> <h6 class="title">Health‐related quality of life</h6> <p>One trial (N = 308) reported on the effect of providing CVD risk scores on health‐related quality of life, measured by the Dutch Euro quality of life (EQ5D‐NL) scale. There was no evidence to suggest that providing CVD risk scores compared with usual care had an effect on quality of life in this one study (effect size −0.006, 95% CI −0.035 to 0.023, I² = 0%; <a href="./references#CD006887-bbs2-0007" title="DenigP , DunM , SchulingJ , Haaijer-RuskampFM , VoorhamJ . The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial. Trials2012;13:219. DenigP , SchulingJ , Haaijer-RuskampF , VoorhamJ . Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ2014;349:g5651. ">Denig 2014</a>). </p> </section> <section id="CD006887-sec-0077"> <h6 class="title">Costs</h6> <p>One trial conducted in Spain reported the effects of providing CVD risk scores on direct costs (<a href="./references#CD006887-bbs2-0006" title="CobosA , VilasecaJ , AsenjoC , Pedro-BotetJ , SanchezE , ValA , et al. Cost effectiveness of a clinical decision support system based on the recommendations of the European Society of Cardiology and other societies for the management of hypercholesterolemia: Report of a cluster-randomized trial. Disease Management and Health Outcomes2005;13(6):421-32. ">Cobos 2005</a>). Providing a CVD risk score to a clinician decreased overall lipid‐lowering medication prescribing rates by decreasing prescriptions in low‐risk individuals. The adjusted mean treatment cost per patient was EUR 237 in the usual care group versus EUR 178 in the intervention group, for a difference of EUR 59 (95% CI 34, 83; P &lt; 0.001), a savings of 25% in treatment costs. Similarly, the adjusted means of the total costs per patient were EUR 283 in the usual care group versus EUR 223 in the intervention group, for a difference of EUR 60 (95% CI 33, 86; P = 0.001), a total savings of 21%. A reduction in lipid‐lowering medication prescribing rates among low‐risk participants was also seen in a quality improvement trial employing a personal digital assistant (PDA) that calculated 10‐year coronary heart disease risk (<a href="./references#CD006887-bbs2-0002" title="BertoniAG , BondsDE , ChenH , HoganP , CragoL , RosenbergerE , et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Archives of Internal Medicine2009;169:678-86. ">Bertoni 2009</a>); however, investigators performed no formal cost‐effectiveness analysis. Likewise, <a href="./references#CD006887-bbs2-0003" title="Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. British Journal of General Practice1994;44:62-7. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ1994;308:313-20. ">British Family Heart 1994</a> did not perform a formal cost‐effectiveness analysis, but based on the observed risk factor changes and the projected reduction in coronary events, the authors suggested that the modest improvements did not support broader implementation of the intervention. </p> </section> </section> </section> <section id="CD006887-sec-0078"> <h4 class="title">Subgroup and sensitivity analyses</h4> <p>We performed a subgroup analysis evaluating the effects of providing CVD risk scores on CVD risk factor levels (total cholesterol, LDL‐cholesterol, systolic blood pressure, diastolic blood pressure, and multivariable CVD risk) by use of clinical decision‐support tools to provide CVD risk scores. Results were similar in magnitude and direction, but substantial heterogeneity remained for all analyses (<a href="./references#CD006887-fig-0024" title="">Analysis 2.1</a>; <a href="./references#CD006887-fig-0025" title="">Analysis 2.2</a>; <a href="./references#CD006887-fig-0026" title="">Analysis 2.3</a>; <a href="./references#CD006887-fig-0027" title="">Analysis 2.4</a>; <a href="./references#CD006887-fig-0028" title="">Analysis 2.5</a>). </p> <p>Due to the substantial heterogeneity observed for CVD risk factor levels, we also performed post hoc subgroup analyses evaluating the effects of providing CVD risk scores by use of health IT and by trials that exclusively enrolled participants with higher risk (defined as 10‐year CVD risk ≥ 10% or a high‐risk condition such as diabetes mellitus). For subgroup analyses by use of health IT, results were similar in magnitude and direction, but substantial heterogeneity remained for all analyses (<a href="./references#CD006887-fig-0029" title="">Analysis 3.1</a>; <a href="./references#CD006887-fig-0030" title="">Analysis 3.2</a>; <a href="./references#CD006887-fig-0031" title="">Analysis 3.3</a>; <a href="./references#CD006887-fig-0032" title="">Analysis 3.4</a>; <a href="./references#CD006887-fig-0033" title="">Analysis 3.5</a>). In contrast, heterogeneity for the effects of providing CVD risk scores on total cholesterol and LDL cholesterol was attenuated when including trials that exclusively enrolled higher‐risk participants (MD −0.13 mmol/L, 95% CI −0.22 to −0.03, I² = 34%; 3 studies, N = 4105 for total cholesterol, <a href="./references#CD006887-fig-0034" title="">Analysis 4.1</a>; and MD −0.07 mmol/L, 95% CI −0.11 to −0.03, I² = 0%; 3 studies, N = 14,219 for LDL cholesterol, <a href="./references#CD006887-fig-0035" title="">Analysis 4.2</a>). This attenuation of heterogeneity was not seen for systolic blood pressure (<a href="./references#CD006887-fig-0036" title="">Analysis 4.3</a>), diastolic blood pressure (<a href="./references#CD006887-fig-0037" title="">Analysis 4.4</a>), or multivariable CVD risk (<a href="./references#CD006887-fig-0038" title="">Analysis 4.5</a>), which may reflect the greater emphasis on risk‐based treatment in cholesterol guidelines compared with blood pressure guidelines. </p> <p>We did not identify sufficient data to perform subgroup analyses by sex or trial design (RCT versus quasi‐RCT). Additionally, after reading study protocols, it was often unclear whether CVD risk scores were provided directly to patients or to clinicians because frequently CVD risk scores were provided to both within the context of a clinical encounter. We did not perform sensitivity analyses because we assessed all studies as being at unclear or high risk of bias. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006887-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006887-sec-0079"></div> <section id="CD006887-sec-0080"> <h3 class="title" id="CD006887-sec-0080">Summary of main results</h3> <p>The trials identified in this systematic review provide low‐quality evidence that current strategies for providing CVD risk scores in primary prevention may have little to no effect on CVD events compared with usual care. However, only three studies reported this outcome, and all had limitations. Compared with usual care, providing CVD risk scores may reduce CVD risk factors like cholesterol, blood pressure and multivariable CVD risk by a small amount and may reduce adverse events, but results were imprecise. There was substantial heterogeneity for many analyses, particularly when analysing change in risk factor levels. This was likely a result of: diverse risk levels of the participants recruited for the studies; the multifaceted and varying nature of the interventions tested; different baseline medication treatment rates; and the different outcomes collected. Given this heterogeneity, readers should interpret results with caution.<br/><br/>Providing CVD risk scores may increase prescriptions for new or intensified lipid‐lowering medications, new or intensified antihypertensive medications, and new aspirin therapy in higher‐risk people. Further, providing CVD risk scores may increase smoking cessation and may reduce decisional conflict compared with usual care. However, providing CVD risk scores may have little to no effect on medication adherence or health‐related quality of life. Measurement of exercise and diet was highly variable among the included studies, and the effects of providing CVD risk scores on these outcomes were mixed. Data on costs were also limited but suggest a reduction in healthcare costs after providing CVD risks scores. Full reporting of effect sizes and quality of evidence ratings for main outcomes are listed in <a href="./full#CD006887-tbl-0001">summary of findings Table 1</a>. </p> </section> <section id="CD006887-sec-0081"> <h3 class="title" id="CD006887-sec-0081">Overall completeness and applicability of evidence</h3> <p>This review provides the most contemporary appraisal of the evidence to date. We identified 73 records of 41 studies (N = 193,614), 8 ongoing studies, and 3 studies awaiting classification. This compares with only four trials (N = 4648) identified in two previous systematic reviews addressing a similar objective and using Cochrane methodology (<a href="./references#CD006887-bbs2-0141" title="BrindleP , BeswickA , FaheyT , EbrahimS . Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart2006;92(12):1752-9. [PMID: 16621883]">Brindle 2006</a>; <a href="./references#CD006887-bbs2-0137" title="BeswickAD , BrindleP , FaheyT , EbrahimS . A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PMID: 21834196]">Beswick 2008</a>). We employed broad selection criteria that led to the inclusion of a wide range of trials with different designs, risk levels among participants, and choices of outcomes. CVD risk score interventions also ranged from simple CVD risk score presentations to multifaceted interventions that incorporated different risk messages, clinical decision support tools, electronic reminders, patient activation material, audit and feedback, and nurse‐led counselling sessions. These inclusive selection criteria led to substantial heterogeneity in many of our pooled estimates. However, they also enhance the external validity of our findings due to the varied settings, populations, and interventions studied in the trials. Although many CVD prevention guidelines recommend the use of multivariable CVD risk scores to guide primary prevention treatment strategies (<a href="./references#CD006887-bbs2-0135" title="AndersonTJ , GrégoireJ , HegeleRA , CoutureP , ManciniGB , McPhersonR , et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Canadian Journal of Cardiology2013;29(2):151-67. [PMID: 23351925]">Anderson 2013</a>; <a href="./references#CD006887-bbs2-0157" title="National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation2002;106(25):3143-421. [PMID: 12485966]">NCEP 2002</a>; <a href="./references#CD006887-bbs2-0158" title="National Institute for Health and Care Excellence (NICE). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181 (accessed 20 January 2016).">NICE 2014</a>; <a href="./references#CD006887-bbs2-0160" title="PiepoliMF , HoesAW , AgewallS , AlbusC , BrotonsC , CatapanoAL , et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts). European Heart Journal2016;37(29):2315-81. [PMID: 27222591]">Piepoli 2016</a>; <a href="./references#CD006887-bbs2-0166" title="StoneNJ , RobinsonJ , LichtensteinAH , Bairey MerzCN , BlumCB , EckelRH , et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014;129(25 Suppl 2):S1-45. [PMID: 24222016]">Stone 2014</a>; <a href="./references#CD006887-bbs2-0169" title="World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO Press, 2007.">WHO 2007</a>), we identified multiple evidence gaps to guide the application of CVD risk scores in clinical practice. Trials generally had a short‐term focus, had methodological limitations particularly in the domains of attrition bias and detection bias, and were underpowered for clinical endpoints. Given the multifactorial nature of many of the CVD risk score interventions, it is also unclear which component of the intervention was most effective at improving CVD prevention. Thus, there is uncertainty about optimal implementation of CVD risk scores in practice to improve cardiovascular health outcomes. </p> </section> <section id="CD006887-sec-0082"> <h3 class="title" id="CD006887-sec-0082">Quality of the evidence</h3> <p>Using the GRADE framework, we rated the quality of evidence guiding the clinical application of CVD risk scores in primary CVD prevention as low overall. Quality assessments were generally downgraded due to: study limitations across multiple risk of bias domains; inconsistency of results due to the substantial unexplained heterogeneity in pooled estimates; and imprecision. Specifically, we rated the quality of evidence for the effects of providing CVD risk scores on CVD events as low, downgrading due to study limitations and imprecision. We rated the quality of evidence for the effects of providing CVD risk scores on CVD risk factor levels (total cholesterol, systolic blood pressure, and multivariable CVD risk) as low, downgrading due to study limitations and inconsistency. We rated the quality of evidence for the effects of providing CVD risk scores on adverse events as low, downgrading due to study limitations and imprecision. We rated the quality of evidence for the effects of providing CVD risk scores on new or intensified lipid‐lowering medications and antihypertensive medications as low, downgrading due to study limitations and inconsistency. </p> </section> <section id="CD006887-sec-0083"> <h3 class="title" id="CD006887-sec-0083">Potential biases in the review process</h3> <p>Our review has several strengths. First, we followed a pre‐specified, published protocol to guide our systematic review and noted any deviations from this protocol. Second, we conducted a comprehensive, transparent search strategy that was guided by an information specialist (MAB) and that identified published reports, conference abstracts, and clinical trial registers. Third, we included only RCTs or quasi‐RCTs that used a systematic method of allocation to the CVD risk score intervention. Fourth, we performed all title screening, data extraction, and risk of bias assessments in duplicate to minimise bias. Fifth, we used the GRADE framework to rate the quality of evidence and factored this quality assessment to guide our conclusions regarding the effects of providing CVD risk scores. </p> <p>The principal limitation of this review is the quality of the available data. Nearly all trials (38 out of 41) had high or unclear risk of bias across multiple domains. Moreover, most trials were powered for process outcomes rather than clinical outcomes, were designed for short duration, did not use systematic follow‐up procedures, and delivered CVD risk messages at a single time point only. Trials also varied in terms of design, risk levels of participants, complexity of CVD risk score interventions, content of risk messages, and choice of outcomes. This heterogeneity is demonstrated in the results of our meta‐analysis and should temper confidence in our reported effect estimates. This inconsistency is also reflected in our GRADE quality assessments. Our selection criteria of trials with all or ≥70% primary prevention participants and where only the intervention group received a multivariable CVD risk score led to the exclusion of several well‐known trials that included a majority of participants with established CVD (<a href="./references#CD006887-bbs2-0059" title="CleveringaFG , GorterKJ , vanden DonkM , RuttenGE . Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care2008;31:2273-5. CleveringaFG , WelsingPM , vanden DonkM , GorterKJ , NiessenLW , RuttenGE , et al. Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk. Diabetes Care2010;33(2):258-63. CleveringaFGW , GorterKJ , vanden DonkM , RuttenGEH . Task delegation and computerised decision support improve cardiovascular risk for type 2 diabetes patients. A randomised controlled trial in primary care. Diabetologia2007;50:S117. ">Cleveringa 2008</a>; <a href="./references#CD006887-bbs2-0083" title="KetolaE , MäkeläM , KlockarsM . Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care. British Journal of General Practice2001;51:291-4. ">Ketola 2001</a>; <a href="./references#CD006887-bbs2-0117" title="WeymillerAJ , MontoriVM , JonesLA , GafniA , GuyattGH , BryantSC , et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Archives of Internal Medicine2007;167(10):1076-82. ">Weymiller 2007</a>). Other prominent but excluded trials provided a CVD risk score to both treatment groups (<a href="./references#CD006887-bbs2-0084" title="KeyserlingTC , SheridanSL , DraegerLB , FinkelsteinEA , GizliceZ , KrugerE , et al. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Internal Medicine2014;174(7):1144-57. SheridanSL , DraegerLB , PignoneMP , SloanePD , Samuel-HodgeC , FinkelsteinEA , et al. Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemporary Clinical Trials2013;36(2):394-405. SheridanSL , KeyserlingTC , DraegerLB . A randomized trial of a web-based versus counselor based intervention to reduce CHD risk. Journal of General Internal Medicine2013;28:S13. ">Keyserling 2014</a>; <a href="./references#CD006887-bbs2-0085" title="BrownSA , JouniH , AustinE , MarroushT , KulloI . Effect of disclosure of genetic risk for coronary heart disease on information seeking and information sharing in a randomized clinical trial (from the MI-GENES Investigators). Circulation2015;132:A16508. KulloIJ , JouniH , AustinEE , BrownSA , KruisselbrinkTM , IssehIN , et al. Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial). Circulation2016;133(12):1181-8. KulloIJ , JouniH , OlsonJE , MontoriVM , BaileyKR . Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study. BMC Medical Genomics2015;8:51. RobinsonCL , JouniH , KruisselbrinkTM , AustinEE , ChristensenKD , GreenRC , et al. Disclosing genetic risk for coronary heart disease: effects on perceived personal control and genetic counseling satisfaction. Clinical Genetics2016;89(2):251-7. RobinsonCL , JouniH , KruisselbrinkTM , ChristensenKD , GreenRC , KulloIJ . The effect of disclosing genetic risk for coronary heart disease on perceived personal control and genetic counseling satisfaction: the MI-genes study. Circulation2014;130:A20188. ">Kullo 2016</a>). Nevertheless, we feel that our inclusive definition of a CVD risk score intervention and the methods we used to select and evaluate the evidence outweigh these limitations. </p> </section> <section id="CD006887-sec-0084"> <h3 class="title" id="CD006887-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>Our results are consistent with prior systematic reviews performed on this topic. Two previous systematic reviews performed with Cochrane methodology identified no strong evidence that CVD risk scores improved health outcomes (<a href="./references#CD006887-bbs2-0137" title="BeswickAD , BrindleP , FaheyT , EbrahimS . A systematic review of risk scoring methods and clinical decision aids used in the primary prevention of coronary heart disease (Supplement). London (UK): Royal College of General Practitioners; May 2008. NICE Clinical Guidelines No. 67S. [PMID: 21834196]">Beswick 2008</a>; <a href="./references#CD006887-bbs2-0141" title="BrindleP , BeswickA , FaheyT , EbrahimS . Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart2006;92(12):1752-9. [PMID: 16621883]">Brindle 2006</a>). However, both reviews searched literature through 2004 and only included interventions that provided a CVD risk score to clinicians. Therefore, they identified only four studies (N = 4648). In contrast, our search was performed through March 2016 and included CVD risk score assessment provided directly to patients or performed at the health system level. Consequently, we identified a greater number of trials and were able to provide greater detail about the effects of CVD risk scores on a variety of intermediate outcomes and health behaviours. Other systematic reviews have also highlighted that CVD risk scores can increase patients’ intent to start therapy and physicians’ prescribing of cardiovascular medications with no evidence of harm (<a href="./references#CD006887-bbs2-0163" title="SheridanSL , CrespoE . Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research2008;8:60. [PMID: 18366711]">Sheridan 2008</a>; <a href="./references#CD006887-bbs2-0164" title="SheridanSL , VieraAJ , KrantzMJ , IceCL , SteinmanLE , PetersKE , et al. The effect of giving global coronary risk information to adults: a systematic review. Archives of Internal Medicine2010;170(3):230-9. [PMID: 20142567]">Sheridan 2010</a>). However, these reviews did not systematically collect or report effects of CVD risk scores on individual risk factor levels or cardiovascular outcomes. </p> <p>Our results complement the findings of a recently published non‐Cochrane systematic review that evaluated the effect of providing a CVD risk score on clinical outcomes (<a href="./references#CD006887-bbs2-0167" title="Usher-SmithJA , SilarovaB , SchuitE , MoonsKG , GriffinSJ . Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review. BMJ Open2015;5(10):e008717.">Usher‐Smith 2015</a>). This review identified 17 trials (N = 19,036) and reported a small reduction in modelled CVD risk (−0.39%, 95% CI −0.71 to −0.07); a trend toward lower mean total or LDL cholesterol (−0.11 mmol/L, 95% CI −0.23 to 0.01); an increase in lipid‐lowering and antihypertensive medication prescribing in high‐risk participants (RR 2.11, 95% CI 1.27 to 3.49 and RR 2.38, 95% CI 1.11 to 5.10, respectively); and mixed effects on smoking cessation, physical activity, and alcohol consumption. Notably, this review did not identify evidence that providing CVD risk scores had an effect on blood pressure level (systolic blood pressure: −0.82 mmHg, 95% CI −2.70 to 1.05; diastolic blood pressure: −0.48 mmHg, 95% CI −1.41 to 0.44). This review, however, has notable limitations. For example, it included non‐randomised, before‐after studies at high risk of selection bias. Additionally, the authors did not use a systematic framework, such as GRADE, to assess the quality of evidence or guide recommendations. Lastly, the authors used restrictive inclusion criteria that led to the exclusion of many contemporary trials that incorporated CVD risk score interventions within complex, multifaceted interventions. Our review addresses many of these limitations by including only RCTs or quasi‐RCTs, using GRADE to assess the quality of evidence, and including trials with multifaceted interventions such as <a href="./references#CD006887-bbs2-0026" title="PanarettoKS , PeirisD , UsherwoodT , HarrisM , HuntJ , PatelA . Health Tracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care?Circulation2012;125:e808. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , PatelB , et al. The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare. BMJ Open2012;2(6):e002177. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , RedfernJ , et al. Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial. Circulation: Cardiovascular Quality and Outcomes2015;8:87-95. PeirisD , UsherwoodT , PanarettoK , HarrisM , HuntJ , ZwarN , et al. Effect of a multi-faceted quality improvement intervention to improve cardiovascular disease risk identification and management in Australian primary health care: the torpedo cluster-randomised trial. Global Heart2014;9:e28. ">Peiris 2015</a>, where provision of a CVD risk score was just one component of a larger implementation model. Thus, our review may provide a more comprehensive and generalisable assessment of the current state of the science. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006887-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006887-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Summary of CVD risk score interventions by included study. Abbreviations: CHD: coronary heart disease; CVD: cardiovascular disease; FRS: Framingham risk score; MI: myocardial infarction; RF: risk factors, RR: risk ratio; UKPDS: United Kingdom Prospective Diabetes Study" data-id="CD006887-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-02.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Summary of CVD risk score interventions by included study.<br/>Abbreviations: CHD: coronary heart disease; CVD: cardiovascular disease; FRS: Framingham risk score; MI: myocardial infarction; RF: risk factors, RR: risk ratio; UKPDS: United Kingdom Prospective Diabetes Study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-02.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006887-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006887-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.3 Total cholesterol (mmol/L)." data-id="CD006887-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.3 Total cholesterol (mmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.5 Systolic blood pressure (mmHg)." data-id="CD006887-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.5 Systolic blood pressure (mmHg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.7 Change in multivariable CVD risk." data-id="CD006887-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 CVD risk score versus no CVD risk score/usual care, outcome: 1.7 Change in multivariable CVD risk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 1: CVD events" data-id="CD006887-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 1: CVD events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 2: CVD events, excluding Bucher 2010" data-id="CD006887-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 2: CVD events, excluding Bucher 2010 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 3: Total cholesterol" data-id="CD006887-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 3: Total cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 4: Low‐density lipoprotein cholesterol" data-id="CD006887-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 4: Low‐density lipoprotein cholesterol </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 5: Systolic blood pressure" data-id="CD006887-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 5: Systolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 6: Diastolic blood pressure" data-id="CD006887-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 6: Diastolic blood pressure </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 7: Change in multivariable CVD risk" data-id="CD006887-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 7: Change in multivariable CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 8: Adverse events (investigator defined)" data-id="CD006887-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 8: Adverse events (investigator defined) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 9: Anxiety" data-id="CD006887-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 9: Anxiety</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 10: New/intensified lipid‐lowering medication" data-id="CD006887-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 10: New/intensified lipid‐lowering medication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 11: New/intensified antihypertensive medication" data-id="CD006887-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 11: New/intensified antihypertensive medication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 12: New aspirin" data-id="CD006887-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 12: New aspirin </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 13: Medication adherence" data-id="CD006887-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 13: Medication adherence </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 14: Smoking cessation" data-id="CD006887-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 14: Smoking cessation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 15: Exercise" data-id="CD006887-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 15: Exercise</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 16: Decisional conflict" data-id="CD006887-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: CVD risk score versus no CVD risk score/usual care, Outcome 16: Decisional conflict </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 1: Total cholesterol by decision support use" data-id="CD006887-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 1: Total cholesterol by decision support use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 2: Low‐density lipoprotein cholesterol by decision support" data-id="CD006887-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 2: Low‐density lipoprotein cholesterol by decision support </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 3: Systolic blood pressure by decision support use" data-id="CD006887-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 3: Systolic blood pressure by decision support use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 4: Diastolic blood pressure by decision support use" data-id="CD006887-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 4: Diastolic blood pressure by decision support use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 5: Change in multivariable CVD risk by decision support" data-id="CD006887-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: CVD risk score versus no CVD risk score/usual care by decision support use, Outcome 5: Change in multivariable CVD risk by decision support </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 1: Total cholesterol by health IT use" data-id="CD006887-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 1: Total cholesterol by health IT use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 2: Low‐density lipoprotein cholesterol by health IT use" data-id="CD006887-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 2: Low‐density lipoprotein cholesterol by health IT use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 3: Systolic blood pressure by health IT use" data-id="CD006887-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 3: Systolic blood pressure by health IT use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 4: Diastolic blood pressure by health IT use" data-id="CD006887-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 4: Diastolic blood pressure by health IT use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 5: Change in multivariable CVD risk by health IT use" data-id="CD006887-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: CVD risk score versus no CVD risk score/usual care by health IT use, Outcome 5: Change in multivariable CVD risk by health IT use </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 1: Total cholesterol by risk status" data-id="CD006887-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 1: Total cholesterol by risk status </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 2: Low‐density lipoprotein cholesterol by risk status" data-id="CD006887-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 2: Low‐density lipoprotein cholesterol by risk status </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 3: Systolic blood pressure by risk status" data-id="CD006887-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 3: Systolic blood pressure by risk status </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 4: Diastolic blood pressure by risk status" data-id="CD006887-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 4: Diastolic blood pressure by risk status </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 5: Change in multivariable CVD risk by risk status" data-id="CD006887-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: CVD risk score versus no CVD risk score/usual care by risk status of participants, Outcome 5: Change in multivariable CVD risk by risk status </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006887-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/urn:x-wiley:14651858:media:CD006887:CD006887-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Multivariable CVD risk, Outcome 1: Multivariable CVD risk" data-id="CD006887-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_t/tCD006887-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Multivariable CVD risk, Outcome 1: Multivariable CVD risk</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/media/CDSR/CD006887/image_n/nCD006887-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006887-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">CVD risk scoring for the primary prevention of cardiovascular disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CVD risk scoring for the primary prevention of cardiovascular disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population</b> : adults without prevalent cardiovascular disease (primary cardiovascular disease prevention)<br/><b>Setting</b> : outpatient<br/><b>Intervention</b> : providing CVD risk scores<br/><b>Comparison</b>: not providing CVD risk scores/usual care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>N of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with not providing CVD risk scores/usual care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with providing CVD risk scores</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>CVD events<br/>follow‐up: range 1‐10 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.01<br/>(0.95 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99,070<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>53 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/>(51 to 58) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total cholesterol (mmol/L)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean total cholesterol level was 5.1 to 6.6 mmol/L and the range of mean change from baseline in total cholesterol level was 0.09 lower to 0.14 mmol/L higher </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in total cholesterol in the intervention group was 0.10 mmol/L lower<br/>(0.20 lower to 0.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20,437<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systolic blood pressure (mmHg)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean systolic blood pressure level was 124.1 to 159.0 mmHg and the range of mean change from baseline in systolic blood pressure level was 5.3 lower to 1.0 higher mmHg </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in systolic blood pressure in the intervention group was 2.77 mmHg lower<br/>(4.16 lower to 1.38 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32,954<br/>(16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change in multivariable CVD risk (SD)<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>In the comparison group, the range of mean change from baseline in multivariable CVD risk was 5.3 lower to 0.77 higher SDs </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in multivariable CVD risk in the intervention group was 0.21 SDs lower<br/>(0.39 lower to 0.02 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9549<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Standardised mean differences were calculated for this outcome due to the use of different multivariable CVD risk scales. An effect size of ~0.20 SD units reflects a small effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Investigator‐defined adverse events<br/>follow‐up: range 1 month to 1 year </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.72<br/>(0.49 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4630<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>e,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events were defined heterogeneously by investigators and included some events that may have been due to newly prescribed medications rather than the provision of a CVD risk score itself. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000<br/>(13 to 28) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>New/intensified lipid‐lowering medication<br/>follow‐up: median 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.47<br/>(1.15 to 1.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>14,175<br/>(11 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prescribing rates in the comparison group varied among the included trials (range 4% to 22%). Median prescribing rate presented </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/>(123 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>New/intensified antihypertensive medication<br/>follow‐up: median 1 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.51<br/>(1.08 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13,255<br/>(8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Prescribing rates in the comparison group varied among the included trials (range 0% to 27%). Median prescribing rate presented </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>172 per 1000<br/>(123 to 240) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI</b> : confidence interval; <b>RCT</b> : randomised controlled trial; <b>RR</b> : risk ratio; <b>SD</b>: standard deviation. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate quality</b> : we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low quality</b> : our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br/><b>Very low quality</b>: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded due to study limitations, primarily driven by high risk of selection bias in <a href="./references#CD006887-bbs2-0016" title="HoltTA , ThorogoodM , GriffithsF , MundayS , FriedeT , StablesD . Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. British Journal of General Practice2010;60:e137-43. HoltTA , ThorogoodM , GriffithsF , MundayS . Protocol for the 'e-Nudge trial': A randomised controlled trial of electronic feedback to reduce the cardiovascular risk of individuals in general practice [ISRCTN64828380]. Trials2006;7:11. ">Holt 2010</a> and high risk of reporting bias in <a href="./references#CD006887-bbs2-0004" title="BucherHC , RickenbachM , YoungJ , GlassTR , ValletY , BernasconiE , et al. Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy2010;15(1):31-40. ">Bucher 2010</a> and <a href="./references#CD006887-bbs2-0018" title="BaumannS , ToftU , AadahlM , JorgensenT , PisingerC . The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study - a randomized controlled trial. International Journal of Behavioral Nutrition and Physical Activity2015;12:33. JorgensenT , JacobsenRK , ToftU , AadahlM , GlumerC , PisingerC . Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ2014;348:g3617. JorgensenT , LadelundS , Borch-JohnsenK , PisingerC , SchraderAM , ThomsenT , et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine2009;48:242-6. PisingerC , GlumerC , ToftU , vonHuth SmithL , AadahlM , Borch-JohnsenK , et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Preventive Medicine2008;46(6):579-84. ToftU , KristoffersenL , LadelundS , OvesenL , LauC , Borch-JohnsenK , et al. The impact of a population-based multi-factorial lifestyle intervention on changes in long-term dietary habits: the Inter99 study. Preventive Medicine2008;47(4):378-83. Von Huth SmithL , LadelundS , Borch-JohnsenK , JorgensenT . A randomized multifactorial intervention study for prevention of ischaemic heart disease (Inter99): the long-term effect on physical activity. Scandinavian Journal of Public Health2008;36(4):380-8. ">Jorgensen 2014</a>.<br/><sup>b</sup>Downgraded due to imprecision; trials reported being underpowered for CVD events.<br/><sup>c</sup>Downgraded due to study limitations, primarily in the domains of attrition bias (missing data for follow‐up risk factor levels) and other sources of bias (poor intervention fidelity, potential conflicts of interest).<br/><sup>d</sup>Downgraded due to heterogeneity in pooled estimates.<br/><sup>e</sup>Downgraded due to study limitations, primarily in the domains of attrition bias (missing data for medication prescribing in follow‐up) and other sources of bias (poor intervention fidelity, potential conflicts of interest).<br/><sup>f</sup>Downgraded due to imprecision, because confidence interval includes 1 and sample size does not meet threshold for optimal information size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">CVD risk scoring for the primary prevention of cardiovascular disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/full#CD006887-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006887-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 CVD events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.95, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 CVD events, excluding Bucher 2010 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.94, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.20, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Low‐density lipoprotein cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.10, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.77 [‐4.16, ‐1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.12 [‐2.11, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Change in multivariable CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.39, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Adverse events (investigator defined) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4630</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.49, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.27, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 New/intensified lipid‐lowering medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.15, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 New/intensified antihypertensive medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [1.08, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 New aspirin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [1.24, 5.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Medication adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.92, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Smoking cessation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.13, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Exercise <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.90, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Decisional conflict <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.57, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006887-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by decision support use</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Total cholesterol by decision support use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.20, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.20, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 No decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.27, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Low‐density lipoprotein cholesterol by decision support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.10, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.10, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 No decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.25, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Systolic blood pressure by decision support use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.77 [‐4.16, ‐1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐3.52, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 No decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.57 [‐6.89, ‐2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Diastolic blood pressure by decision support use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.12 [‐2.11, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.29, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 No decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.09 [‐3.33, ‐0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Change in multivariable CVD risk by decision support <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.39, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.27, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 No decision support use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.98, 0.46]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by decision support use</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006887-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by health IT use</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Total cholesterol by health IT use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.20, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.20, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 No health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.27, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Low‐density lipoprotein cholesterol by health IT use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.10, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21739</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.10, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 No health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.25, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Systolic blood pressure by health IT use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.77 [‐4.16, ‐1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐3.52, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 No health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.57 [‐6.89, ‐2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Diastolic blood pressure by health IT use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.12 [‐2.11, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐1.29, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 No health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.09 [‐3.33, ‐0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Change in multivariable CVD risk by health IT use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.39, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.26, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 No health IT use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.69, 0.39]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by health IT use</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006887-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by risk status of participants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Total cholesterol by risk status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.20, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 High‐risk participants only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.22, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Participants of all risk levels</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.23, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Low‐density lipoprotein cholesterol by risk status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.10, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 High‐risk participants only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.11, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Participants of all risk levels</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7903</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.11, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Systolic blood pressure by risk status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.77 [‐4.16, ‐1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 High‐risk participants only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.22 [‐4.04, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Participants of all risk levels</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.96 [‐4.68, ‐1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Diastolic blood pressure by risk status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.12 [‐2.11, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 High‐risk participants only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4091</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.42, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.2 Participants of all risk levels</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐2.26, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Change in multivariable CVD risk by risk status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9549</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.39, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 High‐risk participants only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4038</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.21, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.2 Participants of all risk levels</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.49, 0.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">CVD risk score versus no CVD risk score/usual care by risk status of participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006887-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Multivariable CVD risk</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Multivariable CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1921</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.25, ‐0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Multivariable CVD risk</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006887.pub4/references#CD006887-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006887.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006887-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006887-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006887-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006887-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006887-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD006887-note-0009">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006887-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD006887-note-0008">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006887\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006887\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006887\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006887\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006887\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Oy81c7tH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006887.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006887.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006887.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006887.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006887.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716315490"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006887.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716315494"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006887.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9c7d0bd81bf6',t:'MTc0MDcxNjMxNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 